Characterization O O
of O O
a O O
lipopolysaccharide O O
- O O
targeted O O
monoclonal O O
antibody O O
and O O
its O O
variable O O
fragments O O
as O O
candidates O O
for O O
prophylaxis O O
against O O
the O O
obligate O O
intracellular O O
bacterial O O
pathogen O O
Coxiella Bacteria_B Bacteria_B
burnetii Bacteria_I Bacteria_I
. O O

Our O O
previous O O
study O O
demonstrated O O
that O O
treatment O O
of O O
Coxiella Bacteria_B Bacteria_B
burnetii Bacteria_I Bacteria_I
with O O
the O O
phase O O
I O O
lipopolysaccharide O O
( O O
PI O O
- O O
LPS O O
) O O
- O O
targeted O O
monoclonal O O
antibody O O
( O O
MAb O O
) O O
1E4 O O
significantly O O
inhibited O O
C Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
burnetii Bacteria_I Bacteria_I
infection O O
in O O
mice Habitat_B O
, O O
suggesting O O
that O O
1E4 O O
is O O
a O O
protective O O
MAb O O
. O O

To O O
determine O O
whether O O
passive O O
transfer O O
of O O
antibodies O O
( O O
Abs O O
) O O
can O O
provide O O
protection O O
against O O
C Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
burnetii Bacteria_I Bacteria_I
natural O Bacteria_I
infection O O
, O O
we O O
examined O O
if O O
passive O O
transfer O O
of O O
1E4 O O
would O O
protect O O
SCID Habitat_B O
mice Habitat_I O
against O O
C Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
burnetii Bacteria_I Bacteria_I
aerosol Habitat_B Bacteria_I
infection O O
. O O

The O O
results O O
indicated O O
that O O
1E4 O O
conferred O O
significant O O
protection O O
against O O
aerosolized Habitat_B O
C Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
burnetii Bacteria_I Bacteria_I
, O O
suggesting O O
that O O
1E4 O O
may O O
be O O
useful O O
for O O
preventing O O
C Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
burnetii Bacteria_I Bacteria_I
natural O Bacteria_I
infection O O
. O O

To O O
further O O
understand O O
the O O
mechanisms O O
of O O
1E4 O O
- O O
mediated O O
protection O O
and O O
to O O
test O O
the O O
possibility O O
of O O
using O O
humanized O O
1E4 O O
to O O
prevent O O
C Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
burnetii Bacteria_I Bacteria_I
infection O O
, O O
we O O
examined O O
whether O O
the O O
Fab O O
fragment O O
of O O
1E4 O O
( O O
Fab1E4 O O
) O O
, O O
a O O
recombinant O O
murine Habitat_B O
single O O
- O O
chain O O
variable O O
fragment O O
( O O
muscFv1E4 O O
) O O
, O O
and O O
a O O
humanized O O
single O O
- O O
chain O O
variable O O
fragment O O
( O O
huscFv1E4 O O
) O O
retained O O
the O O
ability O O
of O O
1E4 O O
to O O
inhibit O O
C Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
burnetii Bacteria_I Bacteria_I
infection O O
. O O

The O O
results O O
indicated O O
that O O
Fab1E4 O O
, O O
muscFv1E4 O O
, O O
and O O
huscFv1E4 O O
were O O
able O O
to O O
inhibit O O
C Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
burnetii Bacteria_I Bacteria_I
infection O O
in O O
mice Habitat_B O
but O O
that O O
their O O
ability O O
to O O
inhibit O O
C Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
burnetii Bacteria_I Bacteria_I
infection O O
was O O
lower O O
than O O
that O O
of O O
1E4 O O
. O O

In O O
addition O O
, O O
treatment O O
of O O
C Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
burnetii Bacteria_I Bacteria_I
with O O
Fab1E4 O O
, O O
muscFv1E4 O O
, O O
or O O
huscFv1E4 O O
can O O
block O O
C Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
burnetii Bacteria_I Bacteria_I
infection O O
of O O
macrophages Habitat_B O
. O O

Interestingly O O
, O O
treatment O O
of O O
C Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
burnetii Bacteria_I Bacteria_I
with O O
huscFv1E4 O O
can O O
significantly O O
reduce O O
C Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
burnetii Bacteria_I Bacteria_I
infectivity O O
in O O
human Habitat_B Habitat_B
macrophages Habitat_I O
. O O

This O O
report O O
provides O O
the O O
first O O
evidence O O
to O O
demonstrate O O
that O O
the O O
humanized O O
variable O O
fragments O O
of O O
an O O
LPS O O
- O O
specific O O
MAb O O
can O O
neutralize O O
C Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
burnetii Bacteria_I Bacteria_I
infection O O
and O O
appears O O
to O O
be O O
a O O
promising O O
step O O
toward O O
the O O
potential O O
use O O
of O O
a O O
humanized O O
MAb O O
as O O
emergency O O
prophylaxis O O
against O O
C Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
burnetii Bacteria_I Bacteria_I
exposure O O
. O O

Cloning O O
, O O
expression O O
, O O
purification O O
, O O
crystallization O O
and O O
X O O
- O O
ray O O
crystallographic O O
analysis O O
of O O
Rv3168 O O
from O O
Mycobacterium Bacteria_B Bacteria_B
tuberculosis Bacteria_I Bacteria_I
H37Rv Bacteria_I O
. O O

Tuberculosis O O
is O O
a O O
widespread O O
and O O
deadly O O
infectious O O
disease O O
, O O
with O O
one O O
third O O
of O O
the O O
human Habitat_B Habitat_B
population Habitat_I O
already O O
being O O
infected O O
. O O

Aminoglycoside O O
antibiotics O O
have O O
become O O
less O O
effective O O
in O O
recent O O
years O O
owing O O
to O O
antibiotic O O
resistance O O
, O O
which O O
arises O O
primarily O O
through O O
enzymatic O O
modification O O
of O O
the O O
antibiotics O O
. O O

The O O
gene O O
product O O
Rv3168 O O
, O O
a O O
putative O O
aminoglycoside O O
phosphotransferase O O
( O O
APH O O
) O O
, O O
from O O
Mycobacterium Bacteria_B Bacteria_B
tuberculosis Bacteria_I Bacteria_I
was O O
crystallized O O
using O O
the O O
sitting O O
- O O
drop O O
vapour O O
- O O
diffusion O O
method O O
in O O
the O O
presence O O
of O O
0 O O
. O O
2 O O
M O O
calcium O O
acetate O O
, O O
0 O O
. O O
1 O O
M O O
Tris O O
- O O
HCl O O
pH O O
7 O O
. O O
0 O O
and O O
20 O O
% O O
PEG O O
3000 O O
at O O
295 O O
K O Bacteria_B
. O Bacteria_I
X O Bacteria_I
- O O
ray O O
diffraction O O
data O O
were O O
collected O O
to O O
a O O
maximum O O
resolution O O
of O O
1 O O
. O O
67 O O
Å O O
on O O
a O O
synchrotron O O
beamline O O
. O O

The O O
crystal O O
belonged O O
to O O
space O O
group O O
P2 O O
( O O
1 O O
) O O
2 O O
( O O
1 O O
) O O
2 O O
( O O
1 O O
) O O
, O O
with O O
unit O O
- O O
cell O O
parameters O O
a O O
= O O
56 O O
. O O
74 O O
, O O
b O O
= O O
62 O O
. O O
37 O O
, O O
c O O
= O O
103 O O
. O O
61 O O
Å O O
. O O

With O O
one O O
molecule O O
per O O
asymmetric O O
unit O O
, O O
the O O
crystal O O
volume O O
per O O
unit O O
protein O O
weight O O
( O O
V O O
( O O
M O O
) O O
) O O
is O O
2 O O
. O O
91 O O
Å O O
( O O
3 O O
) O O
Da O O
( O O
- O O
1 O O
) O O
. O O

The O O
structure O O
was O O
solved O O
by O O
the O O
single O O
- O O
wavelength O O
anomalous O O
dispersion O O
method O O
and O O
refinement O O
of O O
the O O
selenomethionine O O
structure O O
is O O
in O O
progress O O
. O O

A O O
general O O
strategy O O
for O O
the O O
bacterial O O
expression O O
of O O
amyloidogenic O O
peptides O O
using O O
BCL O O
- O O
XL O O
- O O
1 O O
/ O O
2 O O
fusions O O
. O O

Biophysical O O
studies O O
on O O
amyloidogenic O O
and O O
aggregation O O
- O O
prone O O
peptides O O
often O O
require O O
large O O
quantities O O
of O O
material O O
. O O

However O O
, O O
solid O O
- O O
phase O O
synthesis O O
, O O
handling O O
, O O
and O O
purification O O
of O O
peptides O O
often O O
present O O
challenges O O
on O O
these O O
scales O O
. O O

Recombinant O O
expression O O
is O O
an O O
attractive O O
alternative O O
because O O
of O O
its O O
low O O
cost O O
, O O
the O O
ability O O
to O O
isotopically O O
label O O
the O O
peptides O O
, O O
and O O
access O O
to O O
sequences O O
exceeding O O
approximately O O
50 O O
residues O O
. O O

However O O
, O O
expression O O
systems O O
that O O
seek O O
to O O
solubilize O O
amyloidogenic O O
peptides O O
suffer O O
from O O
low O O
yields O O
, O O
difficult O O
optimizations O O
, O O
and O O
isolation O O
challenges O O
. O O

We O O
present O O
a O O
general O O
strategy O O
for O O
expressing O O
and O O
isolating O O
amyloidogenic O O
peptides O O
in O O
Escherichia Bacteria_B Bacteria_B
coli Bacteria_I Bacteria_I
by O O
fusion O O
to O O
a O O
polypeptide O O
that O O
drives O O
the O O
expression O O
of O O
attached O O
peptides O O
into O O
bacterial O O
inclusion O O
bodies O O
. O O

This O O
scheme O O
minimizes O O
toxicity O O
during O O
bacterial O O
growth O O
and O O
enables O O
the O O
processing O O
and O O
handling O O
of O O
the O O
peptides O O
in O O
denaturing O O
solutions O O
. O O

Immobilized O O
metal O O
affinity O O
chromatography O O
, O O
reverse O O
phase O O
HPLC O O
, O O
and O O
cyanogen O O
bromide O O
cleavage O O
are O O
used O O
to O O
isolate O O
the O O
peptide O O
, O O
followed O O
by O O
further O O
reverse O O
phase O O
HPLC O O
, O O
which O O
yields O O
milligram O O
quantities O O
of O O
the O O
purified O O
peptide O O
. O O

We O O
demonstrate O O
that O O
driving O O
the O O
peptides O O
into O O
inclusion O O
bodies O O
using O O
fusion O O
to O O
BCL O O
- O O
XL O O
- O O
1 O O
/ O O
2 O O
is O O
a O O
general O O
strategy O O
for O O
their O O
expression O O
and O O
isolation O O
, O O
as O O
exemplified O O
by O O
the O O
production O O
of O O
11 O O
peptides O O
species O O
. O O

Lymphogranuloma O O
venereum O O
presenting O O
as O O
perianal Habitat_B O
ulceration O O
: O O
an O O
emerging O O
clinical O O
presentation O O
? O O

An O O
outbreak O O
of O O
lymphogranuloma O O
venereum O O
( O O
LGV O O
) O O
infection O O
has O O
been O O
recognised O O
in O O
the O O
UK O O
since O O
2004 O O
, O O
predominantly O O
affecting O O
HIV Habitat_B O
- Habitat_I O
positive Habitat_I O
men Habitat_I O
who Habitat_I O
have Habitat_I O
sex Habitat_I O
with Habitat_I O
men Habitat_I O
( O O
MSM Habitat_B O
) O O
. O O

Patients Habitat_B Habitat_B
typically O O
present O O
with O O
proctitis O O
symptoms O O
. O O

The O O
prevalence O O
of O O
rectal Habitat_B O
LGV O O
in O O
MSM Habitat_B O
attending Habitat_I O
sexually Habitat_I O
transmitted Habitat_I O
infection Habitat_I O
clinics Habitat_I O
in O O
London O O
is O O
estimated O O
at O O
1 O O
% O O
. O O

Health O O
Protection O O
Agency O O
surveillance O O
has O O
shown O O
a O O
decrease O O
in O O
anorectal Habitat_B O
manifestations O O
despite O O
little O O
demographic O O
change O O
. O O

Two O O
cases O O
of O O
HIV Habitat_B Habitat_B
- Habitat_I Habitat_I
infected Habitat_I Habitat_I
patients Habitat_I Habitat_I
presenting Habitat_I O
with Habitat_I O
isolated Habitat_I O
perianal Habitat_I O
ulcer Habitat_I O
disease Habitat_I O
are O O
reported O O
here O O
. O O

Both O O
cases O O
were O O
confirmed O O
to O O
have O O
rectal Habitat_B O
Chlamydia Bacteria_B Bacteria_B
trachomatis Bacteria_I Bacteria_I
- O O
specific O O
DNA O O
of O O
an O O
LGV O O
associated O O
serovar O O
. O O

As O O
presentations O O
of O O
LGV O O
diversify O O
, O O
further O O
education O O
and O O
surveillance O O
are O O
needed O O
in O O
order O O
to O O
reduce O O
transmission O O
and O O
prevent O O
long O O
- O O
term O O
complications O O
. O O

A O O
strong O O
argument O O
already O O
exists O O
for O O
the O O
incorporation O O
of O O
chlamydia Bacteria_B O
nucleic O O
acid O O
amplification O O
tests O O
in O O
the O O
management O O
of O O
MSM Habitat_B O
with Habitat_I O
proctitis Habitat_I O
; O O
this O O
paper O O
provides O O
evidence O O
that O O
this O O
should O O
be O O
extended O O
to O O
MSM Habitat_B O
with Habitat_I O
perianal Habitat_I O
ulcer Habitat_I O
disease Habitat_I O
. O O

Recurrence O O
of O O
Helicobacter Bacteria_B Bacteria_B
pylori Bacteria_I Bacteria_I
infection O O
1 O O
year O O
after O O
successful O O
treatment O O
: O O
prospective O O
cohort O O
study O O
in O O
the O O
Republic O O
of O O
Yemen O O
. O O

To O O
investigate O O
the O O
prevalence O O
of O O
Helicobacter Bacteria_B Bacteria_B
pylori Bacteria_I Bacteria_I
infection O O
in O O
dyspeptic Habitat_B Habitat_B
patients Habitat_I Habitat_I
in O O
the O O
Republic O O
of O O
Yemen O O
and O O
the O O
recurrence O O
rate O O
1 O O
year O O
after O O
apparently O O
successful O O
eradication O O
. O O

A O O
total O O
of O O
275 O O
patients Habitat_B Habitat_B
with Habitat_I Habitat_I
chronic Habitat_I Habitat_I
dyspepsia Habitat_I Habitat_I
seen O Habitat_I
in O Habitat_I
one O Habitat_I
clinic Habitat_B Habitat_I
were O O
enrolled O O
. O O

Gastric Habitat_B Habitat_B
biopsies Habitat_I Habitat_I
were O O
obtained O O
at O O
endoscopy O O
and O O
H Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
pylori Bacteria_I Bacteria_I
infection O O
was O O
diagnosed O O
using O O
the O O
rapid O O
urease O O
test O O
. O O

Patients Habitat_B Habitat_B
with Habitat_I Habitat_I
H Habitat_I Habitat_I
. Habitat_I Habitat_I
pylori Habitat_I Habitat_I
infection Habitat_I O
were O O
given O O
either O O
clarithromycin O O
or O O
metronidazole O Habitat_B
- O Habitat_I
based O Habitat_I
triple O Habitat_I
therapy O Habitat_I
. O O

Six O O
weeks O O
later O O
H Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
pylori Bacteria_I Bacteria_I
status O O
was O O
assessed O O
using O O
the O O
C O O
- O O
urea O O
breath O O
test O O
( O O
C O O
- O O
UBT O O
) O O
. O O

Those O O
who O O
were O O
negative O O
for O O
H Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
pylori Bacteria_I Bacteria_I
had O O
a O O
further O O
C O O
- O O
UBT O O
after O O
1 O O
year O O
to O O
establish O O
the O O
recurrence O O
rate O O
. O O

The O O
prevalence O O
of O O
H Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
pylori Bacteria_I Bacteria_I
infection O O
at O O
entry O O
to O O
the O O
study O O
was O O
82 O O
. O O
2 O O
% O O
[ O O
95 O O
% O O
confidence O O
interval O O
( O O
CI O O
) O O
78 O O
- O O
87 O O
% O O
] O O
. O O

The O O
overall O O
eradication O O
rate O O
6 O O
weeks O O
after O O
treatment O O
was O O
49 O O
. O O
1 O O
% O O
( O O
95 O O
% O O
CI O O
42 O O
. O O
6 O O
- O O
55 O O
. O O
6 O O
% O O
) O O
by O O
intention O O
- O O
to O O
- O O
treat O O
analysis O O
, O O
and O O
60 O O
% O O
( O O
95 O O
% O O
CI O O
53 O O
- O O
67 O O
% O O
) O O
by O O
per O O
- O O
protocol O O
analysis O O
. O O

Recurrence O O
rate O O
of O O
H Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
pylori Bacteria_I Bacteria_I
infection O O
at O O
1 O O
year O O
was O O
34 O O
% O O
( O O
95 O O
% O O
CI O O
14 O O
- O O
45 O O
% O O
) O O
and O O
the O O
only O O
predictor O O
of O O
recurrence O O
was O O
an O O
excess O O
delta O O
C O O
- O O
UBT O O
value O O
less O O
than O O
3 O O
. O O
5 O O
per O O
million O O
but O O
equal O O
to O O
or O O
greater O O
than O O
2 O O
. O O
5 O O
per O O
million O O
at O O
6 O O
weeks O O
after O O
treatment O O
( O O
odds O O
ratio O O
2 O O
. O O
28 O O
; O O
95 O O
% O O
CI O O
1 O O
. O O
17 O O
- O O
4 O O
. O O
44 O O
; O O
P O O
= O O
0 O O
. O O
028 O O
) O O
. O O

The O O
prevalence O O
of O O
H Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
pylori Bacteria_I Bacteria_I
infection O O
in O O
dyspeptic Habitat_B Habitat_B
patients Habitat_I Habitat_I
in O O
Yemen O O
is O O
very O O
high O O
, O O
the O O
eradication O O
rate O O
with O O
standard O O
triple O O
therapy O O
was O O
unsatisfactory O O
probably O O
because O O
of O O
widespread O O
bacterial O O
resistance O O
due O O
to O O
unrestricted O O
antibiotic O O
use O O
. O O

The O O
recurrence O O
rate O O
of O O
infection O O
at O O
1 O O
year O O
was O O
high O O
, O O
as O O
a O O
result O O
of O O
recrudescence O O
of O O
incompletely O O
eradicated O O
organisms O O
rather O O
than O O
reinfection O O
. O O

Effects O O
of O O
a O O
probiotic Habitat_B O
fermented Habitat_I O
milk Habitat_I O
beverage Habitat_I O
containing O O
Lactobacillus Bacteria_B O
casei Bacteria_I O
strain Bacteria_I O
Shirota Bacteria_I O
on O O
defecation O O
frequency O O
, O O
intestinal Habitat_B O
microbiota Habitat_I O
, O O
and O O
the O O
intestinal Habitat_B O
environment Habitat_I O
of Habitat_I O
healthy Habitat_I Habitat_B
individuals Habitat_I Habitat_I
with Habitat_I Habitat_I
soft Habitat_I Habitat_I
stools Habitat_I Habitat_I
. O O

The O O
effects O O
of O O
drinking O O
a O O
fermented Habitat_B O
milk Habitat_I O
beverage Habitat_I O
that O O
contains O O
Lactobacillus Bacteria_B O
casei Bacteria_I O
strain Bacteria_I O
Shirota Bacteria_I O
( O O
LcS Bacteria_B O
) O O
at O O
40 O O
billion O O
bacterial O O
cells O O
/ O O
bottle Habitat_B O
for O O
4 O O
weeks O O
( O O
probiotics Habitat_B O
, O O
1 O O
bottle Habitat_B O
/ O O
day O O
) O O
on O O
defecation O O
frequency O O
, O O
intestinal Habitat_B Habitat_B
microbiota O Habitat_I
and O O
the O O
intestinal Habitat_B O
environment Habitat_I O
of Habitat_I O
healthy Habitat_I Habitat_B
individuals Habitat_I Habitat_I
with Habitat_I Habitat_I
soft Habitat_I Habitat_I
stools Habitat_I Habitat_I
were O O
evaluated O O
. O O

Thirty O O
- O O
four O O
healthy Habitat_B O
adults Habitat_I O
who O O
had O O
soft Habitat_B O
stools Habitat_I O
were O O
randomised O O
into O O
2 O O
groups O O
, O O
and O O
the O O
effects O O
of O O
a O O
regular O O
4 O O
- O O
week O O
intake O O
of O O
probiotics Habitat_B O
were O O
evaluated O O
by O O
a O O
placebo O O
- O O
controlled O O
, O O
double O O
- O O
blind O O
, O O
parallel O O
- O O
group O O
comparative O O
design O O
. O O

Defecation O O
frequency O O
significantly O O
decreased O O
after O O
the O O
4 O O
- O O
week O O
intake O O
period O O
compared O O
with O O
before O O
the O O
probiotic Habitat_B O
treatment O O
. O O

The O O
stool Habitat_B O
quality O O
significantly O O
improved O O
( O O
hardened O O
) O O
compared O O
to O O
the O O
placebo O O
. O O

Also O O
, O O
the O O
water Habitat_B O
content Habitat_I O
of Habitat_I O
the Habitat_I O
stools Habitat_I O
was O O
lower O O
in O O
the O O
probiotic Habitat_B O
group Habitat_I O
than O O
in O O
the O O
placebo Habitat_B O
group Habitat_I O
. O O

Live O O
LcS Bacteria_B O
was O O
recovered O O
at O O
6 O O
. O O
9 O O
± O O
1 O O
. O O
3 O O
and O O
7 O O
. O O
2 O O
± O O
0 O O
. O O
8 O O
log O O
( O O
10 O O
) O O
CFU O O
per O O
1g O O
of O O
stool Habitat_B O
after O O
2 O O
and O O
4 O O
weeks O O
, O O
respectively O O
, O O
of O O
probiotic Habitat_B O
treatment O O
. O O

The O O
number O O
of O O
bifidobacteria Bacteria_B O
in O O
the O O
stools Habitat_B O
also O O
increased O O
significantly O O
compared O O
with O O
the O O
level O O
before O O
starting O O
the O O
probiotics Habitat_B O
. O O

The O O
organic O O
acid O O
levels O O
( O O
total O O
, O O
acetic O O
acid O O
, O O
propionic O O
acid O O
, O O
and O O
butyric O O
acid O O
) O O
significantly O O
increased O O
compared O O
with O O
the O O
level O O
before O O
intake O O
in O O
both O O
the O O
probiotic Habitat_B O
and O O
placebo Habitat_B O
groups Habitat_I O
, O O
but O O
they O O
returned O O
to O O
the O O
original O O
levels O O
after O O
the O O
end O O
of O O
the O O
intake O O
period O O
. O O

These O O
results O O
suggest O O
that O O
probiotic Habitat_B O
fermented Habitat_I O
milk Habitat_I O
beverage Habitat_I O
has O O
an O O
intestine Habitat_B O
- O O
conditioning O O
effect O O
by O O
improving O O
the O O
frequency O O
of O O
defecation O O
and O O
stool Habitat_B O
quality O O
and O O
increasing O O
the O O
intrinsic O O
bifidobacteria Bacteria_B O
in O O
healthy Habitat_B Habitat_B
individuals Habitat_I Habitat_I
with Habitat_I Habitat_I
soft Habitat_I Habitat_I
stool Habitat_I Habitat_I
. O O

Iron O O
transport O O
in O O
the O O
genus O O
Marinobacter Bacteria_B Bacteria_B
. O O

Marinobacter Bacteria_B Bacteria_B
belong O O
to O O
the O O
class O O
of O O
Gammaproteobacteria Bacteria_B Bacteria_B
and O O
these O O
motile O O
, O O
halophilic O O
or O O
halotolerent O O
bacteria O O
are O O
widely O O
distributed O O
throughout O O
the O O
world Habitat_B O
' Habitat_I O
s Habitat_I O
oceans Habitat_I O
having O O
been O O
isolated O O
from O O
a O O
wide O O
variety O O
of O O
marine Habitat_B Habitat_B
environments Habitat_I O
. O O

They O O
have O O
also O O
been O O
identified O O
as O O
members O O
of O O
the O O
bacterial Habitat_B O
flora Habitat_I O
associated O O
with O O
other O O
marine Habitat_B O
organisms Habitat_I O
. O O

Here O O
, O O
using O O
a O O
combination O O
of O O
natural O Habitat_B
products O Habitat_I
chemistry O Habitat_I
and O O
genomic O O
analysis O O
, O O
we O O
assess O O
the O O
nature O O
of O O
the O O
siderophores O O
produced O O
by O O
this O O
genus O O
and O O
their O O
potential O O
relationship O O
to O O
phylogeny O O
and O O
lifestyle O O
/ O O
ecological O O
niche O O
of O O
this O O
diverse O O
group O O
of O O
organisms O O
. O O

Our O O
analysis O O
shows O O
a O O
wide O O
level O O
of O O
diversity O O
in O O
siderophore O O
based O O
iron O O
uptake O O
systems O O
among O O
this O O
genus O O
with O O
three O O
general O O
strategies O O
: O O
( O O
1 O O
) O O
production O O
and O O
utilization O O
of O O
native O O
siderophores O O
in O O
addition O O
to O O
utilization O O
of O O
a O O
variety O O
of O O
exogenous O O
ones O O
, O O
( O O
2 O O
) O O
production O O
and O O
utilization O O
of O O
native O O
siderophores O O
only O O
, O O
( O O
3 O O
) O O
lack O O
of O O
siderophore O O
production O O
but O O
utilization O O
of O O
exogenous O O
ones O O
. O O

They O O
all O O
share O O
the O O
presence O O
of O O
at O O
least O O
one O O
siderophore O O
- O O
independent O O
iron O O
uptake O O
ABC O O
transport O O
systems O O
of O O
the O O
FbpABC O O
iron O O
metal O O
type O O
and O O
lack O O
the O O
ability O O
for O O
direct O O
transport O O
of O O
ferrous O O
iron O O
. O O

Siderophore O O
production O O
and O O
utilization O O
can O O
be O O
correlated O O
with O O
phylogeny O O
and O O
thus O O
it O O
forms O O
a O O
type O O
of O O
chemotaxonomic O O
marker O O
for O O
this O O
genus O O
. O O

Long O O
- O O
term O O
Helicobacter Bacteria_B Bacteria_B
pylori Bacteria_I Bacteria_I
infection O O
and O O
the O O
development O O
of O O
atrophic O O
gastritis O O
and O O
gastric Habitat_B Habitat_B
cancer O O
in O O
Japan O O
. O O

The O O
incidence O O
of O O
gastric Habitat_B Habitat_B
cancer O Habitat_I
and O O
the O O
prevalence O O
of O O
Helicobacter Bacteria_B Bacteria_B
pylori Bacteria_I Bacteria_I
are O O
high O O
in O O
Japan O O
, O O
so O O
it O O
is O O
an O O
important O O
issue O O
whether O O
long O O
- O O
term O O
H Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
pylori Bacteria_I Bacteria_I
infection O O
leads O O
to O O
chronic O O
atrophic O O
gastritis O O
, O O
considered O O
one O O
of O O
the O O
precursors O O
of O O
gastric Habitat_B Habitat_B
cancer O Habitat_I
. O O

We O O
have O O
reported O O
that O O
the O O
grade O O
of O O
atrophy O O
was O O
higher O O
in O O
H Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
pylori Bacteria_I Bacteria_I
- O O
positive O O
subjects O O
than O O
in O O
H Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
pylori Bacteria_I Bacteria_I
- O O
negative O O
subjects O O
. O O

It O O
has O O
also O O
been O O
reported O O
that O O
the O O
atrophy O O
of O O
gastric Habitat_B Habitat_B
mucosa O Habitat_I
increased O O
in O O
H Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
pylori Bacteria_I Bacteria_I
- O O
infected O O
monkeys O O
compared O O
with O O
control Habitat_B O
monkeys Habitat_I O
in O O
a O O
5 O O
- O O
year O O
follow O O
- O O
up O O
study O O
. O O

Most O O
H Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
pylori Bacteria_I Bacteria_I
infections O O
occur O O
in O O
children Habitat_B Habitat_B
, O O
and O O
atrophy O O
of O O
the O O
gastric Habitat_B Habitat_B
mucosa Habitat_I O
progresses O O
during O O
aging O O
. O O

Long O O
- O O
term O O
data O O
show O O
that O O
H Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
pylori Bacteria_I Bacteria_I
infection O O
can O O
lead O O
to O O
gastric Habitat_B Habitat_B
atrophy O O
and O O
may O O
play O O
an O O
important O O
role O O
in O O
the O O
development O O
of O O
gastric Habitat_B Habitat_B
cancer O Habitat_I
. O O

Interestingly O O
, O O
there O O
was O O
no O O
difference O O
in O O
the O O
prevalence O O
of O O
H Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
pylori Bacteria_I Bacteria_I
between O O
patients Habitat_B Habitat_B
with Habitat_I Habitat_I
chronic Habitat_I Habitat_I
gastritis Habitat_I Habitat_I
and O O
gastric Habitat_B Habitat_B
cancer O O
in O O
Japan O O
, O O
but O O
the O O
prevalence O O
of O O
H Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
pylori Bacteria_I Bacteria_I
in O O
young Habitat_B O
Japanese Habitat_I O
gastric Habitat_I Habitat_B
cancer Habitat_I Habitat_I
patients Habitat_I Habitat_I
was O O
significantly O O
higher O O
than O O
in O O
the O O
control O O
group O O
. O O

These O O
data O O
clearly O O
show O O
that O O
H Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
pylori Bacteria_I Bacteria_I
infection O O
is O O
one O O
of O O
the O O
risk O O
factors O O
of O O
gastric Habitat_B Habitat_B
cancer O Habitat_I
in O Habitat_I
young Habitat_B Habitat_I
Japanese Habitat_I Habitat_I
people Habitat_I Habitat_I
, O O
There O O
is O O
no O O
answer O O
to O O
whether O O
curing O O
H Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
pylori Bacteria_I Bacteria_I
infection O O
can O O
reverse O O
the O O
atrophy O O
of O O
the O O
gastric Habitat_B Habitat_B
mucosa O Habitat_I
and O O
decrease O O
the O O
risk O O
of O O
gastric Habitat_B Habitat_B
cancer O Habitat_I
development O Habitat_I
. O O

To O O
clarify O O
this O O
issue O O
, O O
an O O
intervention O O
study O O
must O O
be O O
done O O
. O O

A O O
large O O
clinical O O
trial O O
called O O
the O O
Japanese O O
Intervention O O
Trial O O
of O O
H Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
pylori Bacteria_I Bacteria_I
is O O
in O O
progress O O
. O O

Atypical O O
mycobacteria Bacteria_B Bacteria_B
causing O O
non O O
- O O
pulmonary Habitat_B O
disease O O
in O O
Queensland O O
. O O

During O O
the O O
period O O
1971 O O
- O O
- O O
7 O O
, O O
the O O
Tuberculosis O O
Reference O O
Laboratory O O
in O O
Queensland O O
dealt O O
with O O
52 O O
isolates O O
of O O
atypical O O
mycobacteria Bacteria_B Bacteria_B
made O O
from O O
non O O
- O O
pulmonary Habitat_B O
sites O O
under O O
circumstances O O
suggesting O O
complicity O O
in O O
disease O O
. O O

Twenty O O
- O O
four O O
isolates O O
belonging O O
to O O
the O O
MAIS O O
complex O O
were O O
associated O O
with O O
lymph Habitat_B O
node Habitat_I O
infections O O
in O O
children Habitat_B Habitat_B
. O O

Twelve O O
isolates O O
belonged O O
to O O
the O O
M Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
fortuitum Bacteria_I Bacteria_I
- Bacteria_I O
chelonei Bacteria_I O
complex Bacteria_I O
; O O
most O O
were O O
from O O
superficial Habitat_B O
abscesses Habitat_I O
. O O

Five O O
cases O O
of O O
M Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
marinum Bacteria_I Bacteria_I
infection O O
and O O
8 O O
of O O
M Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
ulcerans Bacteria_I Bacteria_I
disease O O
were O O
detected O O
. O O

Serotypes O O
of O O
Vibrio Bacteria_B Bacteria_B
parahaemolyticus Bacteria_I Bacteria_I
from O O
clinical Habitat_B O
and O O
environmental O O
sources O O
in O O
Togo O O
( O O
West O O
Africa O O
) O O
. O O

Serological O O
analysis O O
of O O
O O O
and O O
K O O
antigens O O
was O O
performed O O
on O O
343 O O
strains O O
of O O
Vibro Bacteria_B Bacteria_B
parahaemolyticus Bacteria_I Bacteria_I
isolated O O
from O O
clinical Habitat_B O
and O O
environmental O O
sources O O
in O O
Togo O O
. O O

Only O O
two O O
strains O O
were O O
not O O
typable O O
by O O
the O O
available O O
O O O
antisera O O
. O O

K O O
untypable O O
strains O O
were O O
found O O
in O O
4 O O
. O O
8 O O
% O O
of O O
isolates O O
from O O
gastroenteritis Habitat_B Habitat_B
patients Habitat_I Habitat_I
, O O
in O O
11 O O
% O O
from O O
healthy Habitat_B O
carriers Habitat_I O
, O O
and O O
in O O
47 O O
% O O
and O O
46 O O
% O O
of O O
isolates O O
, O O
respectively O O
, O O
from O O
water Habitat_B O
and O O
fish Habitat_B Habitat_B
samples Habitat_I Habitat_I
. O O

Thirteen O O
serotypes O O
identified O O
in O O
Togo O O
are O O
not O O
considered O O
in O O
the O O
Japanese O O
antigenic O O
scheme O O
. O O

The O O
suitability O O
of O O
the O O
Japanese O O
typing O O
scheme O O
for O O
geographic O O
areas O O
outside O O
of O O
Japan O O
is O O
discussed O O
and O O
its O O
extension O O
is O O
suggested O O
. O O

Clonal O O
strains O O
of O O
Pseudomonas Bacteria_B Bacteria_B
aeruginosa Bacteria_I Bacteria_I
in O O
paediatric Habitat_B Habitat_B
and O O
adult Habitat_B O
cystic O O
fibrosis O O
units O O
. O O

Despite O O
recent O O
reports O O
of O O
clonal O O
strains O O
of O O
Pseudomonas Bacteria_B Bacteria_B
aeruginosa Bacteria_I Bacteria_I
in O O
cystic Habitat_B O
fibrosis Habitat_I O
( Habitat_I O
CF Habitat_I O
) Habitat_I O
units Habitat_I O
, O O
the O O
need O O
for O O
routine O O
microbiological O O
surveillance O O
remains O O
contentious O O
. O O

Sputum Habitat_B O
was O O
collected O O
prospectively O O
from O O
productive Habitat_B O
patients Habitat_I Habitat_B
attending O O
the O O
regional O O
paediatric Habitat_B O
and O O
adult Habitat_B O
CF O O
units O O
in O O
Brisbane O O
, O O
Australia O O
. O O

All O O
P Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
aeruginosa Bacteria_I Bacteria_I
isolates O O
were O O
typed O O
using O O
pulsed O O
- O O
field O O
gel O O
electrophoresis O O
. O O

Spirometry O O
, O O
anthropometrics O O
, O O
hospitalisations O O
and O O
antibiotic O O
sensitivity O O
data O O
were O O
recorded O O
. O O

The O O
first O O
100 O O
sputum Habitat_B O
samples O O
( O O
first O O
50 O O
patients Habitat_B Habitat_B
at O Habitat_I
each O Habitat_I
clinic Habitat_B Habitat_I
) O Habitat_I
harboured O O
163 O O
isolates O O
of O O
P Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
aeruginosa Bacteria_I Bacteria_I
. O O

A O O
total O O
of O O
39 O O
patients Habitat_B Habitat_B
shared O O
a O O
common O O
strain O O
( O O
pulsotype O O
2 O O
) O O
, O O
20 O O
patients Habitat_B Habitat_B
shared O O
a O O
strain O O
with O O
at O O
least O O
one O O
other O O
patient Habitat_B O
and O O
41 O O
patients Habitat_B Habitat_B
harboured O O
unique O O
strains O O
. O O

Eight O Habitat_B
patients Habitat_B Habitat_I
shared O O
a O O
strain O O
identical O O
to O O
a O O
previously O O
reported O O
Australian O O
transmissible O O
strain O O
( O O
pulsotype O O
1 O O
) O O
. O O

Compared O O
with O O
the O O
unique O O
strain O O
group O O
, O O
patients Habitat_B Habitat_B
harbouring O O
pulsotype O O
2 O O
were O O
younger O O
and O O
had O O
poorer O O
lung Habitat_B O
function O O
. O O

Treatment O O
requirements O O
were O O
similar O O
in O O
these O O
two O O
groups O O
, O O
as O O
were O O
the O O
rates O O
of O O
multiresistance O O
. O O

In O O
conclusion O O
, O O
59 O O
% O O
of O O
patients Habitat_B Habitat_B
harboured O O
a O O
clonal O O
strain O O
, O O
supporting O O
the O O
need O O
for O O
routine O O
microbiological O O
surveillance O O
. O O

In O O
contrast O O
to O O
previously O O
described O O
clonal O O
strains O O
, O O
the O O
dominant O O
pulsotype O O
was O O
indistinguishable O O
from O O
nonclonal O O
strains O O
with O O
respect O O
to O O
both O O
colonial O O
morphology O O
and O O
multiresistance O O
. O O

The O O
clinical O O
significance O O
of O O
clonal O O
strains O O
remains O O
uncertain O O
and O O
requires O O
longitudinal O O
study O O
. O O

Evaluation O O
of O O
antibacterial O O
activity O O
of O O
synthetic O O
aliphatic O O
and O O
aromatic O O
monoacylglycerols O O
. O O

The O O
antibacterial O O
activity O O
of O O
synthetic O O
aliphatic O O
and O O
aromatic O O
monoacylglycerols O O
( O O
MAGs O O
) O O
was O O
studied O O
against O O
two O O
human Habitat_B Habitat_B
pathogens O O
: O O
Staphylococcus Bacteria_B Bacteria_B
aureus Bacteria_I Bacteria_I
and O O
Escherichia Bacteria_B Bacteria_B
coli Bacteria_I Bacteria_I
. O O

The O O
active O O
compounds O O
inhibited O O
selectively O O
S Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
aureus Bacteria_I Bacteria_I
. O O

The O O
most O O
active O O
compounds O O
amongst O O
them O O
were O O
those O O
with O O
medium O O
size O O
aliphatic O O
chain O O
and O O
aromatic O O
MAGs O O
with O O
electron O O
withdrawing O O
substituents O O
at O O
the O O
aryl O O
ring O O
. O O

The O O
introduction O O
of O O
one O O
or O O
two O O
- O O
carbon O O
spacer O O
between O O
the O O
aryl O O
ring O O
and O O
the O O
carboxylic O O
function O O
did O O
not O O
influence O O
antibacterial O O
effectiveness O O
. O O

Neutrophils Habitat_B O
are O O
resistant O O
to O O
Yersinia Bacteria_B O
YopJ O O
/ O O
P O O
- O O
induced O O
apoptosis O O
and O O
are O O
protected O O
from O O
ROS O O
- O O
mediated O O
cell Habitat_B O
death O O
by O O
the O O
type O O
III O O
secretion O O
system O O
. O O

The O O
human Habitat_B O
innate O O
immune O O
system O O
relies O O
on O O
the O O
coordinated O O
activity O O
of O O
macrophages Habitat_B O
and O O
polymorphonuclear Habitat_B Habitat_B
leukocytes Habitat_I Habitat_I
( O O
neutrophils Habitat_B Habitat_B
or O O
PMNs Habitat_B O
) O O
for O O
defense O O
against O O
bacterial O O
pathogens O O
. O O

Yersinia Bacteria_B O
spp O O
. O O

subvert O O
the O O
innate Habitat_B O
immune Habitat_I O
response O O
to O O
cause O O
disease O O
in O O
humans Habitat_B Habitat_B
. O O

In O O
particular O O
, O O
the O O
Yersinia Bacteria_B O
outer O O
protein O O
YopJ O O
( O O
Y Bacteria_B O
. Bacteria_I O
pestis Bacteria_I O
and O O
Y Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
pseudotuberculosis Bacteria_I Bacteria_I
) O O
and O O
YopP O O
( O O
Y Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
enterocolitica Bacteria_I Bacteria_I
) O O
rapidly O O
induce O O
apoptosis O O
in O O
murine Habitat_B Habitat_B
macrophages Habitat_I Habitat_I
and O Habitat_I
dendritic O Habitat_I
cells O Habitat_I
. O O

However O O
, O O
the O O
effects O O
of O O
Yersinia Bacteria_B Bacteria_B
Yop O Bacteria_I
J O Bacteria_I
/ O Bacteria_I
P O Bacteria_I
on O O
neutrophil Habitat_B Habitat_B
fate O O
are O O
not O O
clearly O O
defined O O
. O O

In O O
this O O
study O O
, O O
we O O
utilized O O
wild O O
- O O
type O O
and O O
mutant O O
strains O O
of O O
Yersinia Bacteria_B O
to O O
test O O
the O O
contribution O O
of O O
YopJ O O
and O O
YopP O O
on O O
induction O O
of O O
apoptosis O O
in O O
human Habitat_B Habitat_B
monocyte O Habitat_I
- O Habitat_I
derived O Habitat_I
macrophages O Habitat_I
( O O
HMDM Habitat_B O
) O O
and O O
neutrophils Habitat_B Habitat_B
. O O

Whereas O O
YopJ O O
and O O
YopP O O
similarly O O
induced O O
apoptosis O O
in O O
HMDMs Habitat_B O
, O O
interaction O O
of O O
human Habitat_B Habitat_B
neutrophils O Habitat_I
with O O
virulence O O
plasmid O O
- O O
containing O O
Yersinia Bacteria_B O
did O O
not O O
result O O
in O O
PMN Habitat_B O
caspase O O
activation O O
, O O
release O O
of O O
LDH O O
, O O
or O O
loss O O
of O O
membrane O O
integrity O O
greater O O
than O O
PMN Habitat_B O
controls O O
. O O

In O O
contrast O O
, O O
interaction O O
of O O
human Habitat_B Habitat_B
PMNs Habitat_B Habitat_I
with O Habitat_I
the O Habitat_I
virulence O Habitat_I
plasmid O Habitat_I
- O Habitat_I
deficient O Habitat_I
Y Bacteria_B Habitat_I
. Bacteria_I Habitat_I
pestis Bacteria_I Habitat_I
strain Bacteria_I O
KIM6 Bacteria_I O
resulted O O
in O O
increased O O
surface O O
exposure O O
of O O
phosphatidylserine O O
( O O
PS O O
) O O
and O O
cell Habitat_B Habitat_B
death O O
. O O

PMN Habitat_B O
reactive O O
oxygen O O
species O O
( O O
ROS O O
) O O
production O O
was O O
inhibited O O
in O O
a O O
virulence O O
plasmid O O
- O O
dependent O O
but O O
YopJ O O
/ O O
YopP O O
- O O
independent O O
manner O O
. O O

Following O O
phagocytic O O
interaction O O
with O O
Y Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
pestis Bacteria_I Bacteria_I
strain Bacteria_I Bacteria_I
KIM6 Bacteria_I Bacteria_I
, O O
inhibition O O
of O O
PMN Habitat_B O
ROS O O
production O O
with O O
diphenyleneiodonium O O
chloride O O
resulted O O
in O O
a O O
reduction O O
of O O
PMN Habitat_B Habitat_B
cell Habitat_I Habitat_I
death O O
similar O O
to O O
that O O
induced O O
by O O
the O O
virulence O O
plasmid O O
- O O
containing O O
strain O O
Y Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
pestis Bacteria_I Bacteria_I
KIM5 Bacteria_I Bacteria_I
. O O

Our O O
findings O O
showed O O
that O O
Yersinia Bacteria_B O
YopJ O O
and O O
/ O O
or O O
YopP O O
did O O
not O O
induce O O
pronounced O O
apoptosis O O
in O O
human Habitat_B Habitat_B
neutrophils O Habitat_I
. O O

Furthermore O O
, O O
robust O O
PMN Habitat_B O
ROS O O
production O O
in O O
response O O
to O O
virulence O O
plasmid O O
- O O
deficient O O
Yersinia Bacteria_B O
was O O
associated O O
with O O
increased O O
PMN Habitat_B O
cell Habitat_I O
death O O
, O O
suggesting O O
that O O
Yersinia Bacteria_B O
inhibition O O
of O O
PMN Habitat_B O
ROS O O
production O O
plays O O
a O O
role O O
in O O
evasion O O
of O O
the O O
human Habitat_B Habitat_B
innate Habitat_I O
immune Habitat_I O
response O O
in O O
part O O
by O O
limiting O O
PMN Habitat_B O
apoptosis O O
. O O

Methods O O
for O O
the O O
detection O O
of O O
a O O
specific O O
Mycobacterium Bacteria_B Bacteria_B
leprae Bacteria_I Bacteria_I
antigen O O
in O O
the O O
urine Habitat_B O
of Habitat_I O
leprosy Habitat_I Habitat_B
patients Habitat_I Habitat_I
. O O

Two O O
methods O O
for O O
detecting O O
the O O
phenolic O O
glycolipid O O
, O O
PGL O O
- O O
1 O O
, O O
a O O
Mycobacterium Bacteria_B Bacteria_B
leprae Bacteria_I Bacteria_I
- O O
specific O O
molecule O O
, O O
in O O
the O O
urine Habitat_B O
of Habitat_I O
leprosy Habitat_I Habitat_B
patients Habitat_I Habitat_I
are O O
described O O
. O O

Both O O
methods O O
rely O O
on O O
the O O
100 O O
- O O
fold O O
preconcentration O O
of O O
the O O
urine Habitat_B O
, O O
which O O
can O O
be O O
accomplished O O
by O O
a O O
single O O
- O O
step O O
ultrafiltration O O
procedure O O
. O O

The O O
equivalent O O
of O O
approximately O O
2 O O
. O O
5 O O
micrograms O O
of O O
PGL O O
- O O
1 O O
/ O O
ml O O
was O O
detected O O
in O O
the O O
urine Habitat_B Habitat_B
of Habitat_I Habitat_I
LL Habitat_I Habitat_I
patients Habitat_I Habitat_I
with O Habitat_I
an O Habitat_I
inhibition O O
ELISA O O
. O O

The O O
second O O
method O O
, O O
a O O
direct O O
dot O O
- O O
blot O O
assay O O
on O O
nitrocellulose Habitat_B O
paper Habitat_I O
, O O
was O O
much O O
simpler O O
and O O
more O O
sensitive O O
. O O

As O O
little O O
as O O
3 O O
ng O O
of O O
antigen O O
was O O
detected O O
by O O
the O O
dot O O
- O O
blot O O
technique O O
. O O

PGL O O
- O O
1 O O
was O O
detected O O
in O O
the O O
urine Habitat_B Habitat_B
of Habitat_I Habitat_I
LL Habitat_I Habitat_I
patients Habitat_I Habitat_I
. O O

Evaluation O O
of O O
two O O
commercial O O
methods O O
for O O
the O O
detection O O
of O O
Listeria Bacteria_B Bacteria_B
sp Bacteria_I Bacteria_I
. Bacteria_I O

and O O
Listeria Bacteria_B Bacteria_B
monocytogenes Bacteria_I Bacteria_I
in O O
a O O
chicken Habitat_B Habitat_B
nugget Habitat_I Habitat_I
processing Habitat_I Habitat_I
plant Habitat_I Habitat_I
. O O

This O O
study O O
measures O O
the O O
detection O O
performances O O
of O O
two O O
rapid O O
test O O
systems O O
( O O
Listeria O O
Rapid O O
Test O O
Clearview O O
and O O
Bax O O
system O O
) O O
for O O
the O O
screening O O
of O O
Listeria Bacteria_B Bacteria_B
sp Bacteria_I Bacteria_I
. Bacteria_I O

and O O
Listeria Bacteria_B Bacteria_B
monocytogenes Bacteria_I Bacteria_I
, O O
respectively O O
. O O

A O O
total O O
of O O
413 O O
samples O O
from O O
different O O
sources O O
( O O
product O O
from O O
( O O
i O O
) O O
different O O
stages O O
of O O
processing O O
, O O
( O O
ii O O
) O O
different O O
environments O O
, O O
and O O
( O O
iii O O
) O O
different O O
food Habitat_B Habitat_B
handlers O Habitat_I
) O O
, O O
collected O O
from O O
a O O
chicken Habitat_B Habitat_B
nugget Habitat_I Habitat_I
processing Habitat_I Habitat_I
plant Habitat_I Habitat_I
, O O
were O O
analysed O O
by O O
both O O
rapid O O
methods O O
and O O
a O O
cultural O O
method O O
consisting O O
of O O
pre O O
- O O
enrichment O O
, O O
enrichment O O
, O O
and O O
isolation O O
onto O O
selective Habitat_B O
agars Habitat_I O
( O O
PALCAM Habitat_B O
, O O
LPM Habitat_B O
, O O
and O O
HCLA Habitat_B O
) O O
. O O

Overall O O
, O O
results O O
showed O O
an O O
excellent O O
correlation O O
between O O
data O O
obtained O O
using O O
Clearview O O
and O O
the O O
cultural O O
method O O
, O O
with O O
Clearview O O
presenting O O
an O O
efficiency O O
of O O
99 O O
% O O
. O O

Bax O O
showed O O
a O O
lower O O
correlation O O
using O O
the O O
cultural O O
method O O
, O O
with O O
an O O
efficiency O O
of O O
71 O O
. O O
1 O O
% O O
. O O

The O O
type O O
of O O
sample O O
did O O
not O O
affect O O
the O O
efficiency O O
of O O
Clearview O O
, O O
which O O
varied O O
from O O
98 O O
. O O
1 O O
% O O
for O O
product Habitat_B O
samples Habitat_I O
to O O
100 O O
% O O
for O O
environmental O O
and O O
food Habitat_B Habitat_B
handler Habitat_I Habitat_I
samples O Habitat_I
, O O
while O O
for O O
Bax O O
it O O
had O O
a O O
marked O O
influence O O
. O O

Efficiency O O
of O O
Bax O O
varied O O
from O O
as O O
high O O
as O O
100 O O
% O O
for O O
food Habitat_B Habitat_B
handlers O O
to O O
37 O O
. O O
9 O O
% O O
for O O
product Habitat_B O
samples Habitat_I O
. O O

Hg O O
( O O
II O O
) O O
sequestration O O
and O O
protection O O
by O O
the O O
MerR O O
metal O O
- O O
binding O O
domain O O
( O O
MBD O O
) O O
. O O

MerR O O
, O O
the O O
metalloregulator O O
of O O
the O O
bacterial O O
mercury O O
resistance O O
( O O
mer O O
) O O
operon O O
, O O
binds O O
Hg O O
( O O
II O O
) O O
with O O
high O O
affinity O O
. O O

To O O
study O O
the O O
mechanism O O
of O O
metal O O
- O O
induced O O
activation O O
, O O
a O O
small O O
protein O O
was O O
previously O O
engineered O O
embodying O O
in O O
a O O
single O O
polypeptide O O
the O O
metal O O
- O O
binding O O
domain O O
( O O
MBD O O
) O O
ordinarily O O
formed O O
between O O
two O O
monomers O O
of O O
MerR O O
. O O

Here O O
the O O
physiological O O
and O O
biochemical O O
properties O O
of O O
MBD O O
expressed O O
on O O
the O O
cell O Habitat_B
surface O O
or O O
in O O
the O O
cytosol O O
were O O
examined O O
, O O
to O O
better O O
understand O O
the O O
environments O O
in O O
which O O
specific O O
metal O O
binding O O
can O O
occur O O
with O O
this O O
small O O
derivative O O
. O O

Over O O
20 O O
000 O O
surface O O
copies O O
of O O
MBD O O
were O O
expressed O O
per O O
Escherichia Bacteria_B Bacteria_B
coli Bacteria_I Bacteria_I
cell O O
, O O
with O O
metal O O
stoichiometries O O
of O O
approximately O O
1 O O
. O O
0 O O
Hg O O
( O O
II O O
) O O
per O O
MBD O O
monomer O O
. O O

Cells O O
expressing O O
MBD O O
on O O
their O O
surface O O
in O O
rich Habitat_B O
medium Habitat_I O
bound O O
6 O O
. O O
1 O O
- O O
fold O O
more O O
Hg O O
( O O
II O O
) O O
than O O
those O O
not O O
expressing O O
MBD O O
. O O

Although O O
in O O
nature O Habitat_B
cells O Habitat_I
use O O
the O O
entire O O
mer O O
operon O O
to O O
detoxify O O
mercury O O
, O O
it O O
was O O
interesting O O
to O O
note O O
that O O
cells O O
expressing O O
only O O
MBD O O
survived O O
Hg O O
( O O
II O O
) O O
challenge O O
and O O
recovered O O
more O O
quickly O O
than O O
cells O O
without O O
MBD O O
. O O

Cell O O
- O O
surface O O
- O O
expressed O O
MBD O O
bound O O
Hg O O
( O O
II O O
) O O
preferentially O O
even O O
in O O
the O O
presence O O
of O O
a O O
22 O O
- O O
fold O O
molar O O
excess O O
of O O
Zn O O
( O O
II O O
) O O
and O O
when O O
exposed O O
to O O
equimolar O O
Cd O O
( O O
II O O
) O O
in O O
addition O O
. O O

MBD O O
expressed O O
in O O
the O O
cystosol O O
also O O
afforded O O
improved O O
survival O O
from O O
Hg O O
( O O
II O O
) O O
exposure O O
for O O
E Bacteria_B O
. Bacteria_I O
coli Bacteria_I O
and O O
for O O
the O O
completely O O
unrelated O O
bacterium O O
Deinococcus Bacteria_B Bacteria_B
radiodurans Bacteria_I Bacteria_I
. O O

New O O
one O O
- O O
week O O
, O O
low O O
- O O
dose O O
triple O O
therapy O O
for O O
the O O
treatment O O
of O O
duodenal Habitat_B O
ulcer O O
with O O
Helicobacter Bacteria_B Bacteria_B
pylori Bacteria_I Bacteria_I
infection O O
. O O

Antimicrobial O O
therapy O O
is O O
the O O
recommended O O
treatment O O
for O O
duodenal Habitat_B O
ulcer Habitat_I O
associated O O
with O O
Helicobacter Bacteria_B Bacteria_B
pylori Bacteria_I Bacteria_I
infection O O
. O O

The O O
eradication O O
of O O
bismuth O Habitat_B
- O Habitat_I
based O Habitat_I
triple O Habitat_I
therapy O Habitat_I
with O Habitat_I
bismuth O Habitat_I
subcitrate O Habitat_I
, O O
metronidazole O O
and O O
amoxicillin O O
is O O
limited O O
by O O
low O O
compliance O O
, O O
drug O O
resistance O O
and O O
side O O
- O O
effects O O
. O O

Two O O
- O O
week O O
proton O O
pump O O
inhibitor O O
( O O
PPI O O
) O O
- O O
based O O
triple O O
therapy O O
has O O
a O O
higher O O
eradication O O
rate O O
but O O
is O O
costly O O
. O O

This O O
study O O
was O O
designed O O
to O O
compare O O
the O O
efficacy O O
, O O
patient Habitat_B Habitat_B
compliance O O
and O O
cost O O
of O O
short O O
- O O
term O O
PPI O O
- O O
based O O
triple O O
therapy O O
with O O
those O O
of O O
bismuth O Habitat_B
- O Habitat_I
based O Habitat_I
triple O Habitat_I
therapy O Habitat_I
. O O

Ninety O Habitat_B
patients Habitat_B Habitat_I
with Habitat_I Habitat_I
active Habitat_I Habitat_I
duodenal Habitat_I Habitat_I
ulcer Habitat_I Habitat_I
disease Habitat_I O
and Habitat_I O
H Habitat_I Bacteria_B
pylori Habitat_I Bacteria_I
infection Habitat_I O
, O O
proven O O
with O O
the O O
13C O O
- O O
urea O O
breath O O
test O O
and O O
CLO O O
test O O
( O O
Campylobacter Bacteria_B Bacteria_B
- O O
like O O
organism O O
test O O
) O O
were O O
treated O O
randomly O O
in O O
three O O
therapeutic O O
groups O O
: O O
Group O O
A O O
, O O
DeNol O O
120 O O
mg O O
, O O
amoxicillin O O
500 O O
mg O O
and O O
metronidazole O O
250 O O
mg O O
four O O
times O O
a O O
day O O
orally O O
for O O
14 O O
days O O
; O O
Group O O
B O O
, O O
omeprazole O O
20 O O
mg O O
plus O O
clarithromycin O O
500 O O
mg O O
twice O O
a O O
day O O
and O O
amoxicillin O O
500 O O
mg O O
four O O
times O O
a O O
day O O
for O O
14 O O
days O O
; O O
Group O O
C O O
, O O
omeprazole O O
20 O O
mg O O
, O O
clarithromycin O O
250 O O
mg O O
and O O
metronidazole O O
500 O O
mg O O
twice O O
a O O
day O O
for O O
seven O O
days O O
. O O

Nizatidine O O
150 O O
mg O O
twice O O
a O O
day O O
was O O
given O O
continuously O O
following O O
the O O
end O O
of O O
anti O O
- O O
H Bacteria_B O
pylori Bacteria_I O
therapy O O
for O O
each O O
group O O
. O O

Two O O
months O O
later O O
, O O
endoscopy O O
, O O
the O O
CLO O O
test O O
and O O
13C O O
- O O
urea O O
breath O O
test O O
were O O
repeated O O
to O O
assess O O
the O O
eradication O O
rate O O
of O O
H Bacteria_B Bacteria_B
pylori Bacteria_I Bacteria_I
and O O
the O O
ulcer Habitat_B O
- O O
healing O O
rate O O
. O O

Drug O O
tolerance O O
was O O
evaluated O O
by O O
patients Habitat_B Habitat_B
themselves O O
by O O
daily O O
recording O O
of O O
any O O
side O O
- O O
effects O O
. O O

Eighty O O
- O O
four O O
patients Habitat_B Habitat_B
completed O O
the O O
entire O O
course O O
of O O
therapy O O
and O O
evaluation O O
for O O
H Bacteria_B Bacteria_B
pylori Bacteria_I Bacteria_I
infection O O
. O O

The O O
H Bacteria_B Bacteria_B
pylori Bacteria_I Bacteria_I
eradication O O
rates O O
in O O
Groups O O
A O O
, O O
B O O
and O O
C O O
were O O
75 O O
% O O
( O O
21 O O
/ O O
28 O O
) O O
, O O
93 O O
% O O
( O O
26 O O
/ O O
28 O O
) O O
and O O
89 O O
% O O
( O O
25 O O
/ O O
28 O O
) O O
, O O
respectively O O
( O O
p O O
= O O
0 O O
. O O
466 O O
) O O
. O O

The O O
ulcer Habitat_B O
healing O O
rate O O
was O O
86 O O
% O O
( O O
24 O O
/ O O
28 O O
) O O
in O O
Group O O
A O O
and O O
89 O O
% O O
( O O
25 O O
/ O O
28 O O
) O O
in O O
Groups O O
B O O
and O O
C O O
( O O
p O O
= O O
0 O O
. O O
764 O O
) O O
. O O

A O O
total O O
of O O
74 O O
patients Habitat_B Habitat_B
( O O
88 O O
% O O
) O O
were O O
free O O
from O O
symptoms O O
at O O
the O O
end O O
of O O
the O O
triple O O
therapy O O
. O O

Symptom O O
relief O O
was O O
faster O O
in O O
patients Habitat_B Habitat_B
with Habitat_I Habitat_I
PPI Habitat_I Habitat_I
- Habitat_I Habitat_I
based Habitat_I Habitat_I
triple Habitat_I Habitat_I
therapy Habitat_I Habitat_I
( O O
Groups O O
B O O
and O O
C O O
) O O
( O O
days O O
3 O O
and O O
4 O O
) O O
than O O
for O O
patients Habitat_B Habitat_B
with Habitat_I Habitat_I
bismuth Habitat_I Habitat_I
- Habitat_I Habitat_I
based Habitat_I Habitat_I
triple Habitat_I Habitat_I
therapy Habitat_I Habitat_I
( O O
day O O
5 O O
) O O
. O O

The O O
cost O O
of O O
Group O Habitat_B
C O Habitat_I
therapy O Habitat_I
was O O
lower O O
than O O
that O O
for O O
Groups O O
A O O
and O O
B O O
. O O

There O O
were O O
no O O
major O O
side O O
- O O
effects O O
in O O
any O O
of O O
the O O
patients Habitat_B Habitat_B
. O O

One O O
- O O
week O O
triple O O
therapy O O
with O O
omeprazole O O
, O O
clarithromycin O O
and O O
metronidazole O O
is O O
highly O O
effected O O
for O O
the O O
eradication O O
of O O
H Bacteria_B Bacteria_B
pylori Bacteria_I Bacteria_I
. O O

A O O
therapeutic O O
regime O O
of O O
one O O
week O O
' O O
s O O
duration O O
with O O
lower O O
cost O O
, O O
good O O
compliance O O
and O O
mild O O
side O O
- O O
effects O O
may O O
offer O O
a O O
good O O
choice O O
for O O
treatment O O
of O O
duodenal Habitat_B O
ulcer Habitat_I O
associated O O
with O O
H Bacteria_B Bacteria_B
pylori Bacteria_I Bacteria_I
infection O O
in O O
clinical O O
practice O O
. O O

A O O
novel O O
receptor O O
- O O
ligand O O
pathway O O
for O O
entry O O
of O O
Francisella Bacteria_B Bacteria_B
tularensis Bacteria_I Bacteria_I
in O O
monocyte Habitat_B O
- Habitat_I O
like Habitat_I O
THP Habitat_I O
- Habitat_I O
1 Habitat_I O
cells Habitat_I O
: O O
interaction O O
between O O
surface O O
nucleolin O O
and O O
bacterial O O
elongation O O
factor O O
Tu O O
. O O

Francisella Bacteria_B Bacteria_B
tularensis Bacteria_I Bacteria_I
, O O
the O O
causative O O
agent O O
of O O
tularemia O O
, O O
is O O
one O O
of O O
the O O
most O O
infectious O O
human Habitat_B O
bacterial O O
pathogens O O
. O O

It O O
is O O
phagocytosed O O
by O O
immune Habitat_B Habitat_B
cells Habitat_I Habitat_I
, O Habitat_I
such O Habitat_I
as O Habitat_I
monocytes Habitat_B Habitat_I
and O O
macrophages Habitat_B O
. O O

The O O
precise O O
mechanisms O O
that O O
initiate O O
bacterial O O
uptake O O
have O O
not O O
yet O O
been O O
elucidated O O
. O O

Participation O O
of O O
C3 O O
, O O
CR3 O O
, O O
class O O
A O O
scavenger O O
receptors O O
and O O
mannose O O
receptor O O
in O O
bacterial O O
uptake O O
have O O
been O O
already O O
reported O O
. O O

However O O
, O O
contribution O O
of O O
an O O
additional O O
, O O
as O O
- O O
yet O O
- O O
unidentified O O
receptor O O
for O O
F Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
tularensis Bacteria_I Bacteria_I
internalization O O
has O O
been O O
suggested O O
. O O

We O O
show O O
here O O
that O O
cell Habitat_B O
- O O
surface O O
expressed O O
nucleolin O O
is O O
a O O
receptor O O
for O O
Francisella Bacteria_B Bacteria_B
tularensis Bacteria_I Bacteria_I
Live Bacteria_I Bacteria_I
Vaccine Bacteria_I Bacteria_I
Strain Bacteria_I Bacteria_I
( O Bacteria_I
LVS Bacteria_B Bacteria_I
) O O
and O O
promotes O O
LVS Bacteria_B O
binding O O
and O O
infection O O
of O O
human Habitat_B Habitat_B
monocyte Habitat_B Habitat_I
- Habitat_I Habitat_I
like Habitat_I Habitat_I
THP Habitat_I Habitat_I
- Habitat_I Habitat_I
1 Habitat_I Habitat_I
cells Habitat_I Habitat_I
. O O

The O O
HB O O
- O O
19 O O
pseudopeptide O O
that O O
binds O O
specifically O O
carboxy O O
- O O
terminal O O
RGG O O
domain O O
of O O
nucleolin O O
inhibits O O
LVS Bacteria_B O
binding O O
and O O
infection O O
of O O
monocyte Habitat_B O
- Habitat_I O
like Habitat_I O
THP Habitat_I O
- Habitat_I O
1 Habitat_I O
cells Habitat_I O
. O O

In O O
a O O
pull O O
- O O
down O O
assay O O
, O O
elongation O O
factor O O
Tu O O
( O O
EF O O
- O O
Tu O O
) O O
, O O
a O O
GTP O O
- O O
binding O O
protein O O
involved O O
in O O
protein O O
translation O O
, O O
usually O O
found O O
in O O
cytoplasm O O
, O O
was O O
recovered O O
among O O
LVS Bacteria_B O
bacterial O O
membrane O O
proteins O O
bound O O
on O O
RGG O O
domain O O
of O O
nucleolin O O
. O O

A O O
specific O O
polyclonal O O
murine Habitat_B O
antibody O O
was O O
raised O O
against O O
recombinant O O
LVS Bacteria_B O
EF O O
- O O
Tu O O
. O O

By O O
fluorescence O O
and O O
electron O Habitat_B
microscopy O Habitat_I
experiments O Habitat_I
, O O
we O O
found O O
that O O
a O O
fraction O O
of O O
EF O O
- O O
Tu O O
could O O
be O O
detected O O
at O O
the O O
bacterial O O
surface O O
. O O

Anti O O
- O O
EF O O
- O O
Tu O O
antibodies O O
reduced O O
LVS Bacteria_B O
binding O O
to O O
monocyte Habitat_B O
- Habitat_I O
like Habitat_I O
THP Habitat_I O
- Habitat_I O
1 Habitat_I O
cells Habitat_I O
and O O
impaired O O
infection O O
, O O
even O O
in O O
absence O O
of O O
complement O O
and O O
complement O O
receptors O O
. O O

Interaction O O
between O O
EF O O
- O O
Tu O O
and O O
nucleolin O O
was O O
illustrated O O
by O O
two O O
different O O
pull O O
- O O
down O O
assays O O
using O O
recombinant O O
EF O O
- O O
Tu O O
proteins O O
and O O
either O O
RGG O O
domain O O
of O O
nucleolin O O
or O O
cell Habitat_B O
solubilized O O
nucleolin O O
. O O

Altogether O O
, O O
our O O
results O O
demonstrate O O
that O O
the O O
interaction O O
between O O
surface O O
nucleolin O O
and O O
its O O
bacterial O O
ligand O O
EF O O
- O O
Tu O O
plays O O
an O O
important O O
role O O
in O O
Francisella Bacteria_B Bacteria_B
tularensis Bacteria_I Bacteria_I
adhesion O O
and O O
entry O O
process O O
and O O
may O O
therefore O O
facilitate O O
invasion O O
of O O
host Habitat_B O
tissues Habitat_I O
. O O

Since O O
phagosomal O O
escape O O
and O O
intra O O
- O O
cytosolic O O
multiplication O O
of O O
LVS Bacteria_B O
in O O
infected Habitat_B Habitat_B
monocytes Habitat_I Habitat_I
are O O
very O O
similar O O
to O O
those O O
of O O
human Habitat_B Habitat_B
pathogenic O Habitat_I
F Bacteria_B Habitat_I
. Bacteria_I Habitat_I
tularensis Bacteria_I Habitat_I
ssp Bacteria_I Habitat_I
tularensis Bacteria_I Habitat_I
, O O
the O O
mechanism O O
of O O
entry O O
into O O
monocyte Habitat_B O
- Habitat_I O
like Habitat_I O
THP Habitat_I O
- Habitat_I O
1 Habitat_I O
cells Habitat_I O
, O O
involving O O
interaction O O
between O O
EF O O
- O O
Tu O O
and O O
nucleolin O O
, O O
might O O
be O O
similar O O
in O O
the O O
two O O
subspecies O O
. O O

Thus O O
, O O
the O O
use O O
of O O
either O O
nucleolin O O
- O O
specific O O
pseudopeptide O O
HB O O
- O O
19 O O
or O O
recombinant O O
EF O O
- O O
Tu O O
could O O
provide O O
attractive O O
therapeutic O O
approaches O O
for O O
modulating O O
F Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
tularensis Bacteria_I Bacteria_I
infection O O
. O O

Rickettsia Bacteria_B Bacteria_B
infection O O
in O O
five O O
areas O O
of O O
the O O
state O O
of O O
São O O
Paulo O O
, O O
Brazil O O
. O O

This O O
study O O
investigated O O
rickettsial Bacteria_B O
infection O O
in O O
animals Habitat_B Habitat_B
, O O
humans Habitat_B Habitat_B
, O O
ticks Habitat_B O
, O O
and O O
fleas Habitat_B O
collected O O
in O O
five O O
areas O O
of O O
the O O
state O O
of O O
São O O
Paulo O O
. O O

Eight O O
flea Habitat_B O
species O O
( O O
Adoratopsylla Habitat_B O
antiquorum Habitat_I O
antiquorum Habitat_I O
, O O
Ctenocephalides Habitat_B Bacteria_B
felis Habitat_I Bacteria_I
felis Habitat_I Bacteria_I
, O Bacteria_I
Polygenis Habitat_B Bacteria_I
atopus Habitat_I Bacteria_I
, O O
Polygenis Habitat_B O
rimatus Habitat_I O
, O O
Polygenis Habitat_B O
roberti Habitat_I O
roberti Habitat_I O
, O O
Polygenis Habitat_B Bacteria_B
tripus Habitat_I Bacteria_I
, O O
Rhopalopsyllus Habitat_B Bacteria_B
lugubris Habitat_I Bacteria_I
, O O
and O O
Rhopalopsyllus Habitat_B Bacteria_B
lutzi Habitat_I Bacteria_I
lutzi Habitat_I O
) O O
, O O
and O O
five O O
tick Habitat_B O
species O O
( O O
Amblyomma Habitat_B O
aureolatum Habitat_I O
, O O
Amblyomma Habitat_B O
cajennense Habitat_I O
, O O
Amblyomma Habitat_B Bacteria_B
dubitatum Habitat_I Bacteria_I
, O O
Ixodes Habitat_B O
loricatus Habitat_I O
, O O
and O O
Rhipicephalus Habitat_B Bacteria_B
sanguineus Habitat_I Bacteria_I
) O O
were O O
collected O O
from O O
dogs Habitat_B O
, O O
cats Habitat_B O
, O O
and O O
opossums Habitat_B O
. O O

Rickettsia Bacteria_B O
felis Bacteria_I O
was O O
the O O
only O O
rickettsia Bacteria_B O
found O O
infecting O O
fleas Habitat_B O
, O O
whereas O O
Rickettsia Bacteria_B O
bellii Bacteria_I O
was O O
the O O
only O O
agent O O
infecting O O
ticks Habitat_B O
, O O
but O O
no O O
animal Habitat_B O
or O O
human Habitat_B Habitat_B
blood Habitat_I Habitat_I
was O O
shown O O
to O O
contain O O
rickettsial Bacteria_B O
DNA O O
. O O

Testing O O
animal Habitat_B O
and O O
human Habitat_B Habitat_B
sera O Habitat_I
by O O
indirect O O
immunofluorescence O O
assay O O
against O O
four O O
rickettsia Bacteria_B O
antigens O O
( O O
R Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
rickettsii Bacteria_I Bacteria_I
, O O
R Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
parkeri Bacteria_I Bacteria_I
, O O
R Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
felis Bacteria_I Bacteria_I
, O O
and O O
R Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
bellii Bacteria_I Bacteria_I
) O O
, O O
some O O
opossum Habitat_B O
, O O
dog Habitat_B O
, O O
horse Habitat_B O
, O O
and O O
human Habitat_B Habitat_B
sera O Habitat_I
reacted O O
to O O
R Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
rickettsii Bacteria_I Bacteria_I
with O O
titers O O
at O O
least O O
four O O
- O O
fold O O
higher O O
than O O
to O O
the O O
other O O
three O O
rickettsial Bacteria_B O
antigens O O
. O O

These O O
sera Habitat_B O
were O O
considered O O
to O O
have O O
a O O
predominant O O
antibody O O
response O O
to O O
R Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
rickettsii Bacteria_I Bacteria_I
. O O

Using O O
the O O
same O O
criteria O O
, O O
opossum Habitat_B O
, O O
dog Habitat_B O
, O O
and O O
horse Habitat_B O
sera Habitat_I O
showed O O
predominant O O
antibody O O
response O O
to O O
R Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
parkeri Bacteria_I Bacteria_I
or O O
a O O
very O O
closely O O
related O O
genotype O O
. O O

Our O O
serological O O
results O O
suggest O O
that O O
both O O
R Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
rickettsii Bacteria_I Bacteria_I
and O O
R Bacteria_B Habitat_B
. Bacteria_I Habitat_I
parkeri Bacteria_I Habitat_I
infected O Habitat_I
animals Habitat_B Habitat_I
and O O
/ O O
or O O
humans Habitat_B Habitat_B
in O O
the O O
studied O O
areas O O
. O O

Vibrio Bacteria_B Bacteria_B
fetus Bacteria_I Bacteria_I
human Habitat_B Bacteria_I
infection O O
- O O
- O O
isolation O O
from O O
a O O
subacute O O
bacterial O O
endocarditis O O
case O O
. O O

Construction O O
of O O
a O O
cloning O O
vector O O
from O O
a O O
naturally O O
occurring O O
plasmid O O
of O O
Salmonella Bacteria_B Bacteria_B
typhimurium Bacteria_I Bacteria_I
. O O

A O O
naturally O O
occurring O O
plasmid O O
isolated O O
from O O
a O O
drug O O
- O O
resistant O O
strain O O
of O O
Salmonella Bacteria_B Bacteria_B
typhimurium Bacteria_I Bacteria_I
( Bacteria_I O
993 Bacteria_I O
) Bacteria_I O
has O O
been O O
used O O
to O O
construct O O
a O O
plasmid O O
vector O O
for O O
cloning O O
in O O
a O O
wild O O
strain O O
of O O
Salmonella Bacteria_B Bacteria_B
. O O

The O O
strain O O
( Bacteria_B O
993 Bacteria_I O
) Bacteria_I O
contains O O
at O O
least O O
two O O
plasmids O O
. O O

The O O
smaller O O
plasmid O O
( O O
9 O O
kb O O
) O O
contains O O
an O O
ampicillin O O
- O O
resistant O O
marker O O
, O O
while O O
the O O
larger O O
one O O
( O O
25 O O
kb O O
) O O
is O O
cryptic O O
. O O

Physical O O
mapping O O
of O O
the O O
9 O O
- O O
kb O O
plasmid O O
and O O
construction O O
of O O
a O O
3 O O
. O O
5 O O
- O O
kb O O
derivative O O
have O O
been O O
carried O O
out O O
. O O

This O O
plasmid O O
has O O
been O O
used O O
for O O
cloning O O
in O O
a O O
restriction O O
+ O O
modification O O
+ O O
strain O O
of O O
S Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
typhimurium Bacteria_I Bacteria_I
using O O
a O O
conventional O Habitat_B
calcium O Habitat_I
chloride O Habitat_I
method O Habitat_I
. O O

It O O
exhibited O O
better O O
efficiency O O
of O O
transformation O O
than O O
other O O
commonly O O
used O O
plasmids O O
such O O
as O O
pBR322 O O
or O O
its O O
derivatives O O
and O O
transformants O O
were O O
found O O
to O O
be O O
stable O O
in O O
the O O
absence O O
of O O
antibiotic O O
selection O O
. O O

The O O
vector O O
is O O
compatible O O
with O O
pBR322 O O
and O O
can O O
be O O
used O O
to O O
study O O
the O O
expression O O
of O O
cloned O O
genes O O
in O O
minicells O O
. O O

The O O
differential O O
diagnosis O O
of O O
early O O
gastric Habitat_B Habitat_B
mucosa Habitat_I Habitat_I
- O Habitat_I
associated O Habitat_I
lymphoma O Habitat_I
: O Habitat_I
polymerase O Habitat_I
chain O Habitat_I
reaction O O
and O O
paraffin O O
section O O
immunophenotyping O O
. O O

The O O
distinction O O
between O O
benign O O
florid O O
lymphoid O O
hyperplasia O O
and O O
low O O
- O O
grade O O
gastric Habitat_B O
mucosal Habitat_I O
- Habitat_I O
associated Habitat_I O
lymphoid Habitat_I O
tissue Habitat_I O
( O O
MALT Habitat_B O
) O O
lymphoma O O
may O O
be O O
a O O
challenge O O
. O O

The O O
presence O O
of O O
monoclonal Habitat_B Habitat_B
B Habitat_I Habitat_I
cells Habitat_I Habitat_I
in O O
Helicobacter Bacteria_B Bacteria_B
pylori Bacteria_I Bacteria_I
- O O
chronic O O
active O O
gastritis O O
has O O
suggested O O
that O O
polymerase O O
chain O O
reaction O O
( O O
PCR O O
) O O
data O O
should O O
be O O
viewed O O
with O O
caution O O
. O O

We O O
investigated O O
the O O
reliability O O
of O O
PCR O O
versus O O
immunophenotyping O O
in O O
diagnosing O O
early O O
gastric Habitat_B Habitat_B
MALT O Habitat_I
lymphoma O Habitat_I
. O O

We O O
studied O O
1511 O O
biopsies O O
from O O
eight O O
patients Habitat_B Habitat_B
with Habitat_I Habitat_I
high Habitat_I Habitat_I
- Habitat_I Habitat_I
grade Habitat_I Habitat_I
primary Habitat_I Habitat_I
gastric Habitat_I Habitat_I
lymphoma Habitat_I Habitat_I
, O Habitat_I
25 O Habitat_I
with O Habitat_I
low O Habitat_I
- O Habitat_I
grade O Habitat_I
MALT Habitat_B Habitat_I
lymphoma O Habitat_I
, O O
32 O O
with O O
atypical O O
lymphoid O O
infiltrates O O
, O O
and O O
39 O O
with O O
Helicobacter Bacteria_B Bacteria_B
pylori Bacteria_I Bacteria_I
- O O
chronic O O
active O O
gastritis O O
. O O

Paraffin O O
sections O O
from O O
all O O
cases O O
were O O
stained O O
with O O
antibodies O O
to O O
CD20 Habitat_B O
, O O
CD3 Habitat_B O
, O O
AE1 O O
/ O O
AE3 O O
, O O
kappa O O
and O O
lambda O O
. O O

PCR O O
was O O
performed O O
on O O
paraffin O Habitat_B
sections O Habitat_I
using O O
the O O
primer O O
set O O
VH O O
- O O
FR3 O O
/ O O
J O O
( O O
H O O
) O O
. O O

Using O O
histopathology O O
as O O
the O O
gold O O
standard O O
in O O
diagnosis O O
, O O
we O O
confirmed O O
monoclonality O O
in O O
22 O O
of O O
25 O O
MALT Habitat_B O
lymphomas O O
( O O
88 O O
% O O
) O O
; O O
a O O
clonal O O
band O O
was O O
found O O
in O O
38 O O
% O O
( O O
15 O O
of O O
39 O O
) O O
of O O
patients Habitat_B Habitat_B
with Habitat_I Habitat_I
chronic Habitat_I Habitat_I
active Habitat_I Habitat_I
gastritis Habitat_I Habitat_I
. O O

An O O
immunophenotype O O
pattern O O
with O O
predominance O O
of O O
CD20 Habitat_B O
- Habitat_I O
positive Habitat_I O
cells Habitat_I O
in O O
lymphocytic Habitat_B O
infiltrates O O
was O O
associated O O
with O O
monoclonality O O
in O O
92 O O
% O O
of O O
cases O O
. O O

The O O
presence O O
of O O
an O O
enlarged O O
irregular O O
mantle O O
zone O O
was O O
found O O
in O O
both O O
monoclonal O O
and O O
polyclonal O O
areas O O
. O O

An O O
equal O O
prevalence O O
of O O
B O O
and O O
T Habitat_B Habitat_B
cells Habitat_I Habitat_I
in O O
lymphocytic Habitat_B O
infiltrates O O
was O O
associated O O
with O O
a O O
polyclonal O O
pattern O O
in O O
24 O O
of O O
31 O O
cases O O
( O O
77 O O
% O O
) O O
. O O

Immunostaining O O
of O O
sIg O O
( O O
kappa O O
and O O
lambda O O
) O O
was O O
difficult O O
in O O
paraffin O Habitat_B
sections O Habitat_I
and O O
convincing O O
proof O O
of O O
monoclonality O O
was O O
not O O
obtained O O
. O O

Lymphoepithelial Habitat_B Habitat_B
lesions Habitat_I Habitat_I
were O O
infrequent O O
in O O
gastric Habitat_B Habitat_B
biopsies O Habitat_I
and O O
their O O
presence O O
was O O
highlighted O O
with O O
keratin O O
stains O O
. O O

Because O O
monoclonal Habitat_B Habitat_B
B Habitat_I Habitat_I
cells Habitat_I Habitat_I
are O O
observed O O
in O O
Helicobacter Bacteria_B Bacteria_B
pylori Bacteria_I Bacteria_I
- O O
associated O O
gastritis O O
, O O
the O O
correct O O
interpretation O O
of O O
clonality O O
by O O
PCR O O
remains O O
unclear O O
. O O

Paraffin O O
section O O
IHC O O
using O O
CD20 Habitat_B O
and O O
CD3 Habitat_B O
is O O
especially O O
useful O O
to O O
confirm O O
the O O
diagnosis O O
of O O
gastric Habitat_B Habitat_B
MALT O Habitat_I
lymphoma O Habitat_I
. O O

Prevalence O O
of O O
thermotolerant O O
Campylobacter Bacteria_B Bacteria_B
in O O
partridges Habitat_B O
( O O
Perdix Habitat_B O
perdix Habitat_I O
) O O
. O O

To O O
estimate O O
the O O
prevalence O O
of O O
thermotolerant O O
Campylobacter Bacteria_B Bacteria_B
spp Bacteria_I Bacteria_I
. Bacteria_I O

in O O
commercially Habitat_B O
reared Habitat_I O
partridges Habitat_I O
( O O
Perdix Habitat_B O
perdix Habitat_I O
) O O
in O O
southern O O
Italy O O
. O O

Cloacal Habitat_B O
swabs Habitat_I O
of Habitat_I O
partridges Habitat_I O
( O O
n O O
= O O
240 O O
) O O
, O O
equally O O
distributed O O
between O O
male O O
and O O
female Habitat_B Habitat_B
birds Habitat_I Habitat_I
, O O
from O O
a O O
game Habitat_B Habitat_B
bird Habitat_I Habitat_I
farm O Habitat_I
located O O
in O O
the O O
Southern O O
Italy O O
were O O
examined O O
for O O
the O O
prevalence O O
of O O
thermotolerant O O
Campylobacter Bacteria_B Bacteria_B
spp Bacteria_I Bacteria_I
. Bacteria_I O

The O O
samples O O
were O O
processed O O
in O O
order O O
to O O
detect O O
thermotolerant O O
Campylobacter Bacteria_B Bacteria_B
spp Bacteria_I Bacteria_I
. Bacteria_I O

by O O
culture O O
methods O O
. O O

The O O
positive O O
samples O O
were O O
then O O
confirmed O O
by O O
multiplex O O
polymerase O O
chain O O
reaction O O
. O O

Thermotolerant O O
Campylobacter Bacteria_B Bacteria_B
spp Bacteria_I Bacteria_I
. Bacteria_I O

were O O
isolated O O
from O O
118 O O
( O O
49 O O
. O O
2 O O
% O O
) O O
of O O
the O O
240 O O
cloacal Habitat_B O
swabs Habitat_I O
examined O O
. O O

As O O
proved O O
by O O
PCR O O
, O O
100 O O
% O O
of O O
the O O
strains O O
were O O
identified O O
as O O
Campylobacter Bacteria_B Bacteria_B
coli Bacteria_I Bacteria_I
( O O
118 O O
/ O O
118 O O
) O O
, O O
and O O
15 O O
( O O
12 O O
. O O
7 O O
% O O
) O O
out O O
of O O
the O O
118 O O
positive O O
samples O O
were O O
also O O
positive O O
for O O
Campylobacter Bacteria_B Bacteria_B
jejuni Bacteria_I Bacteria_I
. O O

In O O
contrast O O
, O O
Campylobacter Bacteria_B Bacteria_B
lari Bacteria_I Bacteria_I
was O O
not O O
identified O O
. O O

Adult Habitat_B O
partridges Habitat_I O
showed O O
a O O
significantly O O
higher O O
prevalence O O
( O O
P O O
< O O
0 O O
. O O
05 O O
) O O
than O O
younger Habitat_B O
ones Habitat_I O
. O O

These O O
results O O
reinforce O O
the O O
assumption O O
that O O
game Habitat_B O
birds Habitat_I O
may O O
be O O
considered O O
as O O
potential O O
carriers O O
of O O
Campylobacter Bacteria_B Bacteria_B
spp Bacteria_I Bacteria_I
. Bacteria_I O

for O O
human Habitat_B Habitat_B
being O O
and O O
other O O
animal Habitat_B O
species Habitat_I O
. O O

Although O O
an O O
earlier O O
1986 O O
publication O O
described O O
the O O
prevalence O O
of O O
Campylobacter Bacteria_B Bacteria_B
coli Bacteria_I Bacteria_I
in O O
commercially Habitat_B O
reared Habitat_I O
partridges Habitat_I O
, O O
this O O
is O O
the O O
first O O
report O O
to O O
confirm O O
the O O
species O O
of O O
Campylobacter Bacteria_B Bacteria_B
using O O
a O O
PCR O O
test O O
. O O

Quantitative O O
metabolome O O
analysis O O
using O O
liquid O O
chromatography O O
- O O
high O O
- O O
resolution O O
mass O O
spectrometry O O
. O O

In O O
this O O
report O O
, O O
we O O
introduce O O
a O O
liquid O O
chromatography O O
single O O
- O O
mass O O
spectrometry O O
method O O
for O O
metabolome O O
quantification O O
, O O
using O O
the O O
LTQ Habitat_B O
Orbitrap Habitat_I O
high Habitat_I O
- Habitat_I O
resolution Habitat_I O
mass Habitat_I O
spectrometer Habitat_I O
. O O

Analytes O O
were O O
separated O O
with O O
hydrophilic O O
interaction O O
liquid O O
chromatography O O
. O O

At O O
a O O
working O O
resolution O O
of O O
30 O O
, O O
000 O O
( O O
at O O
m O O
/ O O
z O O
400 O O
) O O
, O O
the O O
limit O O
of O O
detection O O
varied O O
from O O
50 O O
fmol O O
to O O
5 O O
pmol O O
for O O
25 O O
metabolites O O
tested O O
. O O

In O O
terms O O
of O O
metabolite O O
concentration O O
, O O
the O O
linearity O O
was O O
about O O
2 O O
to O O
3 O O
orders O O
of O O
magnitude O O
for O O
most O O
compounds O O
( O O
R O O
( O O
2 O O
) O O
> O O
0 O O
. O O
99 O O
) O O
. O O

To O O
determine O O
the O O
accuracy O O
of O O
the O O
system O O
in O O
complex O Habitat_B
sample O Habitat_I
matrices O Habitat_I
, O O
the O O
isotope O O
dilution O O
method O O
was O O
evaluated O O
from O O
mixtures Habitat_B O
of Habitat_I O
pure Habitat_I O
compounds Habitat_I O
and Habitat_I O
uniformly Habitat_I O
13C Habitat_I O
- Habitat_I O
labeled Habitat_I Habitat_B
cell Habitat_I Habitat_I
extracts Habitat_I Habitat_I
. O O

With O O
the O O
application O O
of O O
this O O
method O O
, O O
quantification O O
was O O
possible O O
within O O
single O O
runs O O
even O O
when O O
the O O
pool O O
sizes O O
of O O
individual O O
metabolites O O
varied O O
from O O
0 O O
. O O
13 O O
to O O
55 O O
. O O
6 O O
microM O O
. O O

As O O
a O O
case O O
study O O
, O O
intracellular O O
concentrations O O
of O O
central O Habitat_B
metabolites O Habitat_I
were O O
determined O O
for O O
Methylobacterium Bacteria_B Bacteria_B
extorquens Bacteria_I Bacteria_I
AM1 Bacteria_I Bacteria_I
during O O
growth O O
on O O
two O O
different O O
carbon O O
sources O O
, O O
methanol O O
and O O
succinate O O
. O O

Reproducible O O
results O O
from O O
technical O O
and O O
biological O O
repetitions O O
were O O
obtained O O
that O O
revealed O O
significant O O
variations O O
of O O
intracellular O O
metabolite O O
pool O O
sizes O O
, O O
depending O O
on O O
the O O
carbon O O
source O O
. O O

The O O
LTQ Habitat_B O
Obitrap Habitat_I O
offers O O
new O O
perspectives O O
and O O
strategies O O
for O O
metabolome O O
quantification O O
. O O

Early O O
pregnancy O O
loss O O
and O O
neonatal Habitat_B O
deaths O O
associated O O
with O O
Klebsiella Bacteria_B Bacteria_B
pneumonia Bacteria_I Bacteria_I
infection O O
: O O
a O O
mini O O
review O O
of O O
possible O O
occupational O O
health O O
risk O O
. O O

Recurrent O O
pregnancy O O
loss O O
is O O
a O O
disease O O
of O O
grave O O
psychological O O
and O O
economic O O
concern O O
. O O

The O O
etiology O O
in O O
the O O
vast O O
majority O O
of O O
the O O
cases O O
is O O
unknown O O
or O O
at O O
best O O
poorly O O
understood O O
. O O

Although O O
Klebsiella Bacteria_B Bacteria_B
pneumonia Bacteria_I Bacteria_I
infections O O
have O O
been O O
reported O O
in O O
humans Habitat_B Habitat_B
and O O
animals Habitat_B Habitat_B
during O O
pregnancy O O
, O O
there O O
is O O
hardly O O
any O O
information O O
to O O
indicate O O
whether O O
or O O
not O O
these O O
infections O O
may O O
be O O
responsible O O
for O O
early O O
pregnancy O O
loss O O
. O O

We O O
present O O
a O O
review O O
of O O
literature O O
and O O
report O O
for O O
the O O
first O O
time O O
in O O
humans Habitat_B Habitat_B
, O O
Klebsiella Bacteria_B Bacteria_B
pneumonia Bacteria_I Bacteria_I
infection O O
in O O
placenta Habitat_B O
of Habitat_I O
a Habitat_I O
38 Habitat_I O
- Habitat_I O
year Habitat_I O
- Habitat_I O
old Habitat_I O
secondary Habitat_I O
recurrent Habitat_I O
aborter Habitat_I O
( O O
parity O O
2 O O
+ O O
3 O O
) O O
. O O

Characterization O O
of O O
a O O
mosquitocidal O O
Bacillus Bacteria_B Bacteria_B
thuringiensis Bacteria_I Bacteria_I
serovar Bacteria_I O
sotto Bacteria_I O
strain O O
isolated O O
from O O
Okinawa O O
, O O
Japan O O
. O O

To O O
characterize O O
the O O
mosquitocidal O O
activity O O
of O O
parasporal O O
inclusions O O
of O O
the O O
Bacillus Bacteria_B Bacteria_B
thuringiensis Bacteria_I Bacteria_I
serovar Bacteria_I O
sotto Bacteria_I O
strain Bacteria_I O
96 Bacteria_I O
- Bacteria_I O
OK Bacteria_I O
- Bacteria_I O
85 Bacteria_I O
- Bacteria_I O
24 Bacteria_I O
, O O
for O O
comparison O O
with O O
two O O
well O O
- O O
characterized O O
mosquitocidal O O
strains O O
. O O

The O O
strain O O
96 Bacteria_B O
- Bacteria_I O
OK Bacteria_I O
- Bacteria_I O
85 Bacteria_I O
- Bacteria_I O
24 Bacteria_I O
significantly O O
differed O O
from O O
the O O
existing O O
mosquitocidal O O
B Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
thuringiensis Bacteria_I Bacteria_I
strains O O
in O O
: O O
( O O
1 O O
) O O
lacking O O
the O O
larvicidal O O
activity O O
against O O
Culex Habitat_B Bacteria_B
pipiens Habitat_I Bacteria_I
molestus Habitat_I Bacteria_I
and O O
haemolytic O O
activity O O
, O O
and O O
( O O
2 O O
) O O
SDS O O
- O O
PAGE O O
profiles O O
, O O
immunological O O
properties O O
and O O
N O O
- O O
terminal O O
amino O O
acid O O
sequences O O
of O O
parasporal O O
inclusion O O
proteins O O
. O O

It O O
is O O
clear O O
from O O
the O O
results O O
that O O
the O O
strain O O
96 Bacteria_B O
- Bacteria_I O
OK Bacteria_I O
- Bacteria_I O
85 Bacteria_I O
- Bacteria_I O
24 Bacteria_I O
synthesizes O O
a O O
novel O O
mosquitocidal O O
Cry O O
protein O O
with O O
a O O
unique O O
toxicity O O
spectrum O O
. O O

This O O
is O O
the O O
first O O
report O O
of O O
the O O
occurrence O O
of O O
a O O
mosquitocidal O O
B Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
thuringiensis Bacteria_I Bacteria_I
strain O O
with O O
an O O
unusual O O
toxicity O O
spectrum O O
, O O
lacking O O
the O O
activity O O
against O O
the O O
culicine Habitat_B O
mosquito Habitat_I O
. O O

Association O O
of O O
mutation O O
patterns O O
in O O
GyrA O O
and O O
ParC O O
genes O O
with O O
quinolone O O
resistance O O
levels O O
in O O
lactic Bacteria_B O
acid Bacteria_I O
bacteria Bacteria_I O
. O O

The O O
quinolone O O
resistance O O
of O O
19 O O
lactic Bacteria_B O
acid Bacteria_I O
bacterial Bacteria_I O
strains O O
belonging O O
to O O
the O O
genera O O
Enterococcus Bacteria_B Bacteria_B
and O O
Lactobacillus Bacteria_B O
isolated O O
from O O
the O O
natural Habitat_B Habitat_B
fermented Habitat_I Habitat_I
koumiss Habitat_I Habitat_I
and O Habitat_I
yoghurt Habitat_B Habitat_I
were O O
investigated O O
. O O

The O O
objective O O
of O O
this O O
study O O
was O O
to O O
determine O O
the O O
quinolone O O
resistance O O
levels O O
and O O
to O O
explore O O
the O O
association O O
of O O
the O O
resistance O O
with O O
the O O
mutation O O
patterns O O
in O O
gyrA O O
and O O
parC O O
genes O O
, O O
as O O
is O O
currently O O
recommended O O
by O O
the O O
Food O O
and O O
Agriculture O O
Organization O O
/ O O
World O O
Health O O
Organization O O
Joint O O
Expert O O
Committee O O
in O O
Guidelines O O
for O O
Evaluation O O
of O O
Probiotics O O
in O O
Food O O
for O O
probiotic O O
lactic Bacteria_B O
acid Bacteria_I O
bacteria Bacteria_I O
drug O O
resistance O O
in O O
2001 O O
. O O

The O O
Oxford O O
Cup O O
method O O
and O O
double O O
- O O
tube O O
dilution O O
method O O
were O O
used O O
to O O
determine O O
the O O
quinolone O O
resistance O O
levels O O
of O O
the O O
isolated O O
strains O O
. O O

Generally O O
, O O
all O O
of O O
the O O
19 O O
strains O O
showed O O
resistance O O
towards O O
norfloxacin O O
and O O
ciprofloxacin O O
when O O
the O O
Oxford O O
cup O O
method O O
was O O
used O O
, O O
whereas O O
the O O
incidence O O
was O O
lower O O
( O O
to O O
norfloxacin O O
89 O O
. O O
5 O O
% O O
and O O
to O O
ciprofloxacin O O
68 O O
. O O
4 O O
% O O
) O O
when O O
minimum O O
inhibitory O O
concentration O O
breakpoints O O
( O O
CLSI O O
M100 O O
- O O
S23 O O
) O O
were O O
tested O O
. O O

Furthermore O O
, O O
gene O O
sequencing O O
was O O
conducted O O
on O O
gyrA O O
and O O
parC O O
of O O
topoisomerase O O
II O O
of O O
these O O
isolated O O
strains O O
. O O

The O O
genetic O O
basis O O
for O O
quinolone O O
resistance O O
may O O
be O O
closely O O
related O O
to O O
mutations O O
in O O
gyrA O O
genes O O
as O O
there O O
were O O
10 O O
mutation O O
sites O O
in O O
amino O O
- O O
acid O O
sequences O O
encoded O O
by O O
gyrA O O
genes O O
in O O
10 O O
quinolone O O
resistance O O
strains O O
and O O
14 O O
mutation O O
sites O O
in O O
Enterococcus Bacteria_B Bacteria_B
durans Bacteria_I Bacteria_I
HZ28 Bacteria_I Bacteria_I
, O O
whereas O O
no O O
typical O O
mutations O O
were O O
detected O O
in O O
parC O O
genes O O
. O O

Human Habitat_B O
and O O
tick Habitat_B O
spotted Bacteria_B O
fever Bacteria_I O
group Bacteria_I O
Rickettsia Bacteria_B O
isolates O O
from O O
Israel O O
: O O
a O O
genotypic O O
analysis O O
. O O

The O O
genomes O O
of O O
spotted Bacteria_B O
fever Bacteria_I O
group Bacteria_I O
rickettsiae Bacteria_B O
isolated O O
in O O
different O O
geographical O O
areas O O
of O O
Israel O O
( O O
two O O
from O O
ticks Habitat_B O
and O O
four O O
from O O
humans Habitat_B Habitat_B
, O O
obtained O O
over O O
a O O
span O O
of O O
20 O O
years O O
) O O
were O O
studied O O
by O O
polymerase O O
chain O O
reaction O O
( O O
PCR O O
) O O
and O O
restriction O O
endonuclease O O
fragment O O
length O O
polymorphism O O
( O O
RFLP O O
) O O
analysis O O
. O O

The O O
human Habitat_B Habitat_B
isolates O O
were O O
obtained O O
from O O
patients Habitat_B Habitat_B
suffering Habitat_I O
from Habitat_I O
rickettsial Habitat_I O
disease Habitat_I O
of Habitat_I O
different Habitat_I O
degrees Habitat_I O
of Habitat_I O
severity Habitat_I O
. O O

The O O
PCR O O
products O O
obtained O O
with O O
five O O
pairs O O
of O O
oligonucleotide O O
primers O O
( O O
two O O
primer O O
sets O O
derived O O
from O O
the O O
190 O O
- O O
kDa O O
polypeptide O O
gene O O
and O O
three O O
from O O
the O O
120 O O
- O O
kDa O O
polypeptide O O
gene O O
) O O
and O O
cleaved O O
with O O
restriction O O
endonucleases O O
were O O
used O O
to O O
study O O
the O O
Israeli O O
isolates O O
and O O
reference O O
Rickettsia Bacteria_B O
conorii Bacteria_I O
isolates O O
. O O

Subtle O O
differences O O
between O O
the O O
PCR O O
- O O
RFLP O O
patterns O O
of O O
Israeli O O
isolates O O
and O O
the O O
two O O
R O Bacteria_B
. O Bacteria_I
conorii O Bacteria_I
reference O O
strains O O
( O O
Moroccan O O
and O O
no O O
. O O

7 O O
) O O
were O O
seen O O
when O O
the O O
PCR O O
products O O
derived O O
from O O
the O O
190 O O
- O O
kDa O O
gene O O
- O O
derived O O
primer O O
sets O O
were O O
digested O O
. O O

All O O
of O O
the O O
Israeli O O
isolates O O
were O O
identical O O
by O O
RFLP O O
analysis O O
using O O
all O O
of O O
the O O
primer O O
sets O O
. O O

This O O
study O O
showed O O
that O O
the O O
Israeli O O
spotted Bacteria_B O
fever Bacteria_I O
group Bacteria_I O
isolates O O
( O O
from O O
both O O
ticks Habitat_B O
and O O
humans Habitat_B Habitat_B
) O O
were O O
genetically O O
homogeneous O O
by O O
the O O
criteria O O
used O O
in O O
this O O
study O O
, O O
despite O O
the O O
time O O
and O O
location O O
differences O O
in O O
their O O
original O O
isolation O O
, O O
and O O
different O O
as O O
a O O
group O O
from O O
R Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
conorii Bacteria_I Bacteria_I
. O O

Lipopolysaccharide O O
from O O
nonvirulent O O
Ara Bacteria_B O
+ Bacteria_I O
Burkholderia Bacteria_I Bacteria_B
pseudomallei Bacteria_I Bacteria_I
isolates O O
is O O
immunologically O O
indistinguishable O O
from O O
lipopolysaccharide O O
from O O
virulent O O
Ara Bacteria_B O
- Bacteria_I O
clinical Habitat_B O
isolates O O
. O O

Different O O
lines O O
of O O
evidence O O
suggest O O
that O O
a O O
discrepancy O O
between O O
the O O
distribution O O
of O O
Burkholderia O Bacteria_B
( O O
Pseudomonas O Bacteria_B
) O Bacteria_I
pseudomallei O Bacteria_I
in O O
the O O
environment O O
and O O
the O O
distribution O O
of O O
the O O
disease O O
melioidosis O O
is O O
attributable O O
, O O
at O O
least O O
in O O
part O O
, O O
to O O
phenotypic O O
differences O O
between O O
clinical Habitat_B O
and O O
some O O
environmental O O
isolates O O
. O O

Two O O
antigenically O O
and O O
biochemically O O
distinct O O
biotypes O O
have O O
been O O
described O O
, O O
only O O
one O O
of O O
which O O
is O O
virulent O O
. O O

In O O
this O O
study O O
, O O
lipopolysaccharides O O
( O O
LPSs O O
) O O
were O O
extracted O O
by O O
the O O
proteinase O O
K O O
digestion O O
method O O
from O O
a O O
total O O
of O O
214 O O
B Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
pseudomallei Bacteria_I Bacteria_I
isolates O O
, O O
and O O
their O O
immunoreactivities O O
with O O
sera Habitat_B O
from Habitat_I O
patients Habitat_I Habitat_B
with Habitat_I Habitat_I
different Habitat_I Habitat_I
clinical Habitat_I Habitat_I
spectra Habitat_I O
and Habitat_I O
with Habitat_I O
other Habitat_I O
infections Habitat_I O
were O O
evaluated O O
. O O

With O O
the O O
exception O O
of4 O O
isolates O O
from O O
a O O
total O O
of O O
214 O O
tested O O
, O O
the O O
sodium O O
dodecyl O O
sulfate O O
- O O
polyacrylamide O O
gel O O
electrophoresis O O
silver O O
- O O
staining O O
profiles O O
of O O
the O O
LPSs O O
from O O
the O O
two O O
biotypes O O
showed O O
identical O O
ladder O O
patterns O O
that O O
were O O
typical O O
for O O
smooth O O
LPSs O O
from O O
other O O
gram O O
- O O
negative O O
bacteria O O
. O O

The O O
210 O O
isolates O O
with O O
typical O O
LPS O O
patterns O O
( O O
119 O O
Ara Bacteria_B O
- Bacteria_I O
clinical Habitat_B O
, O O
13 O O
Ara Bacteria_B Habitat_B
- Bacteria_I Habitat_I
soil Habitat_B Habitat_I
, O O
70 O O
Ara Bacteria_B Bacteria_B
+ Bacteria_I Bacteria_I
soil Habitat_B Bacteria_I
, O O
and O O
8 O O
reference O O
National O O
Type O O
Culture O O
Collection O O
strains O O
) O O
also O O
exhibited O O
similar O O
immunoblot O O
profiles O O
against O O
pooled O O
sera Habitat_B O
from Habitat_I O
patients Habitat_I Habitat_B
with Habitat_I Habitat_I
melioidosis Habitat_I Habitat_I
and O Habitat_I
hyperimmune Habitat_B Habitat_I
mouse Habitat_I Habitat_I
sera Habitat_I Habitat_I
. O O

Concordant O O
findings O O
were O O
noted O O
in O O
the O O
indirect O O
enzyme O O
- O O
linked O O
immunosorbent O O
assay O O
with O O
Ara Bacteria_B O
- Bacteria_I O
and O O
Ara Bacteria_B O
+ Bacteria_I O
LPSs O O
to O O
coat O O
the O O
microtiter O O
plates O O
. O O

The O O
LPSs O O
of O O
the O O
different O O
B Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
pseudomallei Bacteria_I Bacteria_I
biotypes O O
appear O O
antigenically O O
indistinguishable O O
. O O

It O O
is O O
, O O
therefore O O
, O O
unlikely O O
that O O
this O O
component O O
is O O
related O O
to O O
the O O
virulence O O
and O O
pathogenicity O O
of O O
B Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
pseudomallei Bacteria_I Bacteria_I
. O O

Ampicillin O O
- O O
resistant O O
Haemophilus Bacteria_B Bacteria_B
influenzae Bacteria_I Bacteria_I
type Bacteria_I O
B Bacteria_I O
possessing O O
a O O
TEM O O
- O O
type O O
beta O O
- O O
lactamase O O
but O O
little O O
permeability O O
barrier O O
to O O
ampicillin O O
. O O

Ampicillin O O
- O O
resistant O O
Haemophilus Bacteria_B Bacteria_B
influenzae Bacteria_I Bacteria_I
type Bacteria_I O
B Bacteria_I O
have O O
been O O
reported O O
only O O
during O O
the O O
past O O
year O O
. O O

Five O O
clinical Habitat_B O
isolates O O
from O O
the O O
U O Bacteria_B
. O Bacteria_I
S O Bacteria_I
. O O
and O O
Germany O O
all O O
had O O
the O O
TEM O O
- O O
type O O
beta O O
- O O
lactamase O O
which O O
is O O
known O O
to O O
be O O
transferred O O
widely O O
among O O
other O O
gram O O
- O O
negative O O
bacilli O O
. O O

Unlike O O
those O O
bacilli O O
, O O
however O O
, O O
the O O
H Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
influenzae Bacteria_I Bacteria_I
cell O O
had O O
very O O
little O O
barrier O O
to O O
entry O O
of O O
penicillins O O
. O O

This O O
greater O O
permeability O O
of O O
the O O
H Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
influenzae Bacteria_I Bacteria_I
cell O O
to O O
penicillins O O
appeared O O
to O O
reduce O O
the O O
protective O O
effect O O
of O O
its O O
beta O O
- O O
lactamase O O
, O O
in O O
that O O
acquisition O O
of O O
the O O
TEM O O
- O O
type O O
beta O O
- O O
lactamase O O
increased O O
levels O O
of O O
resistance O O
to O O
penicillins O O
much O O
less O O
for O O
individual O O
cells O O
of O O
H Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
influenzae Bacteria_I Bacteria_I
than O O
for O O
those O O
of O O
Escherichia Bacteria_B Bacteria_B
coli Bacteria_I Bacteria_I
. O O

Large O O
inocula O O
of O O
either O O
species O O
appeared O O
highly O O
resistant O O
. O O

The O O
unusually O O
low O O
level O O
of O O
resistance O O
of O O
individual O O
cells O O
of O O
H Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
influenzae Bacteria_I Bacteria_I
containing O O
the O O
TEM O O
- O O
type O O
beta O O
- O O
lactamase O O
may O O
have O O
delayed O O
their O O
emergence O O
or O O
recognition O O
, O O
and O O
has O O
unresolved O O
clinical O O
implications O O
. O O

Enhanced O O
virulence O O
of O O
Chlamydia Bacteria_B Bacteria_B
muridarum Bacteria_I Bacteria_I
respiratory Habitat_B Bacteria_I
infections O O
in O O
the O O
absence O O
of O O
TLR2 O O
activation O O
. O O

Chlamydia Bacteria_B Bacteria_B
trachomatis Bacteria_I Bacteria_I
is O O
a O O
common O O
sexually O O
transmitted O O
pathogen O O
and O O
is O O
associated O O
with O O
infant Habitat_B O
pneumonia O O
. O O

Data O O
from O O
the O O
female Habitat_B O
mouse Habitat_I O
model O O
of O O
genital Habitat_B Habitat_B
tract Habitat_I Habitat_I
chlamydia Bacteria_B Habitat_I
infection O O
suggests O O
a O O
requirement O O
for O O
TLR2 O O
- O O
dependent O O
signaling O O
in O O
the O O
induction O O
of O O
inflammation O O
and O O
oviduct Habitat_B O
pathology O O
. O O

We O O
hypothesized O O
that O O
the O O
role O O
of O O
TLR2 O O
in O O
moderating O O
mucosal Habitat_B O
inflammation O O
is O O
site O O
specific O O
. O O

In O O
order O O
to O O
investigate O O
this O O
, O O
we O O
infected O O
mice Habitat_B O
via O O
the O O
intranasal Habitat_B O
route O O
with O O
C Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
muridarum Bacteria_I Bacteria_I
and O O
observed O O
that O O
in O O
the O O
absence O O
of O O
TLR2 O O
activation O O
, O O
mice Habitat_B O
had O O
more O O
severe O O
disease O O
, O O
higher O O
lung Habitat_B O
cytokine O O
levels O O
, O O
and O O
an O O
exaggerated O O
influx O O
of O O
neutrophils Habitat_B Habitat_B
and O O
T Habitat_B Habitat_B
- Habitat_I Habitat_I
cells Habitat_I Habitat_I
into O O
the O O
lungs Habitat_B O
. O O

This O O
could O O
not O O
be O O
explained O O
by O O
impaired O O
bacterial O O
clearance O O
as O O
TLR2 Habitat_B Habitat_B
- Habitat_I Habitat_I
deficient Habitat_I Habitat_I
mice Habitat_I Habitat_I
cleared O O
the O O
infection O O
similar O O
to O O
controls O O
. O O

These O O
data O O
suggest O O
that O O
TLR2 O O
has O O
an O O
anti O O
- O O
inflammatory O O
function O O
in O O
the O O
lung Habitat_B O
during O O
Chlamydia Bacteria_B Bacteria_B
infection O O
, O O
and O O
that O O
the O O
role O O
of O O
TLR2 O O
in O O
mucosal Habitat_B Habitat_B
inflammation O O
varies O O
at O O
different O O
mucosal Habitat_B O
surfaces Habitat_I O
. O O

Isolation O O
, O O
expression O O
and O O
characterization O O
of O O
a O O
minor O O
allergen O O
from O O
Penicillium Habitat_B Bacteria_B
crustosum Habitat_I Bacteria_I
. O O

A O O
ribosomal O O
P1 O O
protein O O
, O O
Pen O O
b O O
26 O O
from O O
Penicillium Habitat_B Bacteria_B
brevicompactum Habitat_I Bacteria_I
, O O
was O O
previously O O
identified O O
as O O
a O O
major O O
allergen O O
. O O

A O O
homolog O O
protein O O
was O O
isolated O O
and O O
characterized O O
from O O
Penicillium Habitat_B Bacteria_B
crustosum Habitat_I Bacteria_I
which O O
is O O
not O O
known O O
to O O
be O O
allergenic O O
mold O O
. O O

A O O
cDNA O O
library O O
of O O
P Habitat_B Bacteria_B
. Habitat_I Bacteria_I
Habitat_I Habitat_I Bacteria_I
crustosum Habitat_I Bacteria_I
was O O
constructed O O
and O O
screened O O
using O O
a O O
probe O O
based O O
on O O
the O O
DNA O O
sequence O O
of O O
Pen O O
b O O
26 O O
. O O

A O O
positive O O
clone O O
was O O
isolated O O
, O O
expressed O O
in O O
Escherichia Bacteria_B Bacteria_B
coli Bacteria_I Bacteria_I
, O O
purified O O
and O O
characterized O O
by O O
comparing O O
its O O
immunological O O
and O O
physical O O
properties O O
to O O
Pen O O
b O O
26 O O
. O O

It O O
was O O
designated O O
as O O
Pen O O
cr O O
26 O O
and O O
had O O
a O O
321 O O
nt O O
ORF O O
corresponding O O
to O O
107 O O
amino O O
acids O O
with O O
a O O
MW O O
of O O
11 O O
O O O
kDa O O
. O O

Pen O O
cr O O
26 O O
had O O
strong O O
sequence O O
homology O O
to O O
Pen O O
b O O
26 O O
( O O
92 O O
% O O
for O O
nucleotides O O
and O O
86 O O
% O O
for O O
amino O O
acids O O
) O O
and O O
its O O
physical O O
and O O
predicted O O
structural O O
properties O O
were O O
similar O O
to O O
the O O
latter O O
. O O

The O O
level O O
of O O
expression O O
of O O
Pen O O
cr O O
26 O O
was O O
much O O
lower O O
than O O
that O O
of O O
Pen O O
b O O
26 O O
in O O
the O O
same O O
expression O O
vector O O
. O O

Both O O
proteins O O
were O O
recognized O O
equally O O
well O O
by O O
the O O
IgG O O
class O O
specific O O
antibodies O O
, O O
but O O
Pen O O
cr O O
26 O O
was O O
poorly O O
recognized O O
by O O
Penicillium Habitat_B O
- Habitat_I O
sensitive Habitat_I O
atopic Habitat_I O
sera Habitat_I O
( O O
IgE O O
) O O
, O O
suggesting O O
striking O O
antigenic O O
difference O O
in O O
IgE O O
epitopes O O
, O O
i O O
. O O
e O O
. O O
, O O
87 O O
% O O
were O O
positive O O
for O O
Pen O O
b O O
26 O O
while O O
only O O
23 O O
% O O
were O O
positive O O
for O O
Pen O O
cr O O
26 O O
. O O

The O O
allergenicity O O
of O O
Pen O O
cr O O
26 O O
seems O O
to O O
be O O
minor O O
in O O
nature O O
and O O
it O O
could O O
be O O
a O O
hypoallergenic O O
variant O O
of O O
Pen O O
b O O
26 O O
. O O

Etiology O O
and O O
epidemiology O O
of O O
diarrhea O O
in O O
children Habitat_B Habitat_B
in O O
Hanoi O O
, O O
Vietnam O O
. O O

This O O
paper O O
provides O O
a O O
preliminary O O
picture O O
of O O
diarrhea O O
with O O
regards O O
to O O
etiology O O
, O O
clinical O O
symptoms O O
, O O
and O O
some O O
related O O
epidemiologic O O
factors O O
in O O
children Habitat_B Habitat_B
less Habitat_I O
than Habitat_I O
five Habitat_I O
years Habitat_I O
of Habitat_I O
age Habitat_I O
living O O
in O O
Hanoi O O
, O O
Vietnam O O
. O O

The O O
study O O
population O O
included O O
587 O O
children Habitat_B Habitat_B
with Habitat_I Habitat_I
diarrhea Habitat_I Habitat_I
and O O
249 O O
age Habitat_B O
- Habitat_I O
matched Habitat_I O
healthy Habitat_I O
controls Habitat_I O
. O O

The O O
identification O O
of O O
pathogens O O
was O O
carried O O
out O O
by O O
the O O
conventional O O
methods O O
in O O
combination O O
with O O
ELISA O O
, O O
immunoseparation O O
, O O
and O O
PCR O O
. O O

The O O
antibiotic O O
susceptibility O O
was O O
determined O O
by O O
MIC O O
following O O
the O O
NCCLS O O
recommendations O O
. O O

Of O O
those O O
with O O
diarrhea O O
, O O
40 O O
. O O
9 O O
% O O
were O O
less O O
than O O
one O O
year O O
old O O
and O O
71 O O
. O O
0 O O
% O O
were O O
less O O
than O O
two O O
years O O
old O O
. O O

A O O
potential O O
pathogen O O
was O O
identified O O
in O O
67 O O
. O O
3 O O
% O O
of O O
children Habitat_B Habitat_B
with Habitat_I Habitat_I
diarrhea Habitat_I Habitat_I
. O O

They O O
were O O
group O O
A O O
rotavirus O O
, O O
diarrheagenic O O
Escherichia Bacteria_B Bacteria_B
coli Bacteria_I Bacteria_I
, O O
Shigella Bacteria_B Bacteria_B
spp Bacteria_I Bacteria_I
, O O
and O O
enterotoxigenic O O
Bacteroides Bacteria_B O
fragilis Bacteria_I O
, O O
with O O
prevalences O O
of O O
46 O O
. O O
7 O O
% O O
, O O
22 O O
. O O
5 O O
% O O
, O O
4 O O
. O O
7 O O
% O O
, O O
and O O
7 O O
. O O
3 O O
% O O
, O O
respectively O O
. O O

No O O
Salmonella Bacteria_B Bacteria_B
spp Bacteria_I Bacteria_I
or O O
Vibrio Bacteria_B Bacteria_B
cholerae Bacteria_I Bacteria_I
were O O
isolated O O
. O O

Rotavirus O O
and O O
diarrheagenic O O
E Bacteria_B O
. Bacteria_I O
coli Bacteria_I O
were O O
predominant O O
in O O
children Habitat_B Habitat_B
less Habitat_I Habitat_I
than Habitat_I Habitat_I
two Habitat_I Habitat_I
years Habitat_I Habitat_I
of Habitat_I Habitat_I
age Habitat_I Habitat_I
, O O
while O O
Shigella Bacteria_B Bacteria_B
spp Bacteria_I Bacteria_I
, O O
and O O
enterotoxigenic O O
B Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
fragilis Bacteria_I Bacteria_I
were O O
mostly O O
seen O O
in O O
the O O
older Habitat_B Habitat_B
children Habitat_I Habitat_I
. O O

Diarrheagenic O O
E Bacteria_B O
. Bacteria_I O
coli Bacteria_I O
and O O
Shigella Bacteria_B Bacteria_B
spp Bacteria_I Bacteria_I
showed O O
high O O
prevalence O O
of O O
resistance O O
to O O
ampicillin O O
, O O
chloramphenicol O O
, O O
and O O
to O O
trimethoprim O O
/ O O
sulfamethoxazole O O
. O O

Children Habitat_B O
attending Habitat_I O
the Habitat_I O
hospitals Habitat_I O
had O O
fever O O
( O O
43 O O
. O O
6 O O
% O O
) O O
, O O
vomiting O O
( O O
53 O O
. O O
8 O O
% O O
) O O
, O O
and O O
dehydration O O
( O O
82 O O
. O O
6 O O
% O O
) O O
. O O

Watery Habitat_B O
stool Habitat_I O
was O O
predominant O O
with O O
a O O
prevalence O O
of O O
66 O O
. O O
4 O O
% O O
, O O
followed O O
by O O
mucous Habitat_B O
stool Habitat_I O
( O O
21 O O
. O O
0 O O
% O O
) O O
. O O

The O O
mean O O
episodes O O
of O O
stools Habitat_B O
per O O
day O O
was O O
seven O O
, O O
ranging O O
from O O
two O O
to O O
23 O O
episodes O O
. O O

Before O O
attending O O
hospitals Habitat_B Habitat_B
, O O
162 O O
/ O O
587 O O
( O O
27 O O
. O O
6 O O
% O O
) O O
children Habitat_B Habitat_B
had O O
been O O
given O O
antibiotics O O
. O O

Overall O O
, O O
more O O
children Habitat_B Habitat_B
got O O
diarrhea O O
in O O
( O O
i O O
) O O
poor O O
families O O
; O O
( O O
ii O O
) O O
families O O
where O O
piped Habitat_B O
water Habitat_I O
and O O
a O O
latrine Habitat_B O
were O O
lacking O O
; O O
( O O
iii O O
) O O
families O O
where O O
mothers Habitat_B O
washed O O
their O O
hands O O
less O O
often O O
before O O
feeding O O
the O O
children Habitat_B Habitat_B
; O O
( O O
iv O O
) O O
families O O
where O O
mothers Habitat_B O
had O O
a O O
low O O
level O O
of O O
education O O
; O O
( O O
v O O
) O O
families O O
where O O
information O O
on O O
health O O
and O O
sanitation O O
less O O
often O O
reached O O
their O O
households O O
. O O

Group O O
A O O
rotavirus O O
, O O
diarrheagenic O O
Escherichia Bacteria_B Bacteria_B
coli Bacteria_I Bacteria_I
, O O
Shigella Bacteria_B Bacteria_B
spp Bacteria_I Bacteria_I
, O O
and O O
enterotoxigenic O O
Bacteroides Bacteria_B O
fragilis Bacteria_I O
play O O
an O O
important O O
role O O
in O O
causing O O
diarrhea O O
in O O
children Habitat_B Habitat_B
in O O
Hanoi O O
, O O
Vietnam O O
. O O

Epidemiological O O
factors O O
such O O
as O O
lack O O
of O O
fresh Habitat_B O
water Habitat_I O
supply Habitat_I O
, O O
unhygienic Habitat_B O
septic Habitat_I O
tank Habitat_I O
, O O
low O O
family O O
income O O
, O O
lack O O
of O O
health O O
information O O
, O O
and O O
low O O
educational O O
level O O
of O O
parents O O
could O O
contribute O O
to O O
the O O
morbidity O O
of O O
diarrhea O O
in O O
children Habitat_B Habitat_B
. O O

Evaluation O O
of O O
the O O
role O O
of O O
Carnobacterium Bacteria_B Bacteria_B
piscicola Bacteria_I Bacteria_I
in O O
spoilage O O
of O O
vacuum Habitat_B O
- Habitat_I O
and Habitat_I O
modified Habitat_I O
- Habitat_I O
atmosphere Habitat_I O
- Habitat_I O
packed Habitat_I O
cold Habitat_I O
- Habitat_I O
smoked Habitat_I O
salmon Habitat_I O
stored Habitat_I O
at Habitat_I O
5 Habitat_I O
degrees Habitat_I O
C Habitat_I O
. O O

The O O
microflora Habitat_B O
on O O
spoiled Habitat_B O
cold Habitat_I O
- Habitat_I O
smoked Habitat_I O
salmon Habitat_I O
often O O
consists O O
of O O
a O O
mixture O O
of O O
lactic Bacteria_B O
acid Bacteria_I O
bacteria Bacteria_I O
( O O
LAB Bacteria_B O
) O O
and O O
Gram O O
- O O
negative O O
bacteria O O
. O O

To O O
elucidate O O
the O O
role O O
of O O
the O O
different O O
groups O O
, O O
a O O
storage O O
trial O O
was O O
carried O O
out O O
in O O
which O O
nisin O O
and O O
CO2 O O
were O O
used O O
for O O
the O O
selective O O
inhibition O O
of O O
the O O
two O O
bacterial O O
groups O O
. O O

The O O
shelf O O
- O O
life O O
of O O
vacuum Habitat_B O
- Habitat_I O
packed Habitat_I O
cold Habitat_I O
- Habitat_I O
smoked Habitat_I O
salmon Habitat_I O
, O O
recorded O O
by O O
sensory O O
evaluation O O
, O O
was O O
four O O
weeks O O
at O O
5 O O
degrees O O
C O O
and O O
the O O
microflora Habitat_B O
was O O
composed O O
of O O
LAB Bacteria_B O
( O O
10 O O
( O O
6 O O
) O O
- O O
10 O O
( O O
7 O O
) O O
cfu O O
/ O O
g O O
) O O
with O O
an O O
associate O O
Gram O O
- O O
negative O O
flora O O
in O O
varying O O
levels O O
( O O
10 O O
( O O
5 O O
) O O
- O O
10 O O
( O O
7 O O
) O O
cfu O O
/ O O
g O O
) O O
. O O

The O O
addition O O
of O O
nisin O O
and O O
/ O O
or O O
a O O
CO2 O O
- O O
atmosphere O O
increased O O
the O O
shelf O O
- O O
life O O
to O O
five O O
or O O
six O O
weeks O O
and O O
limited O O
the O O
level O O
of O O
LAB Bacteria_B O
to O O
about O O
10 O O
( O O
4 O O
) O O
- O O
10 O O
( O O
6 O O
) O O
, O O
10 O O
( O O
3 O O
) O O
- O O
10 O O
( O O
6 O O
) O O
and O O
10 O O
( O O
2 O O
) O O
- O O
10 O O
( O O
4 O O
) O O
cfu O O
/ O O
g O O
, O O
respectively O O
. O O

CO2 O O
- O O
atmosphere O O
+ O O
/ O O
- O O
nisin O O
inhibited O O
the O O
growth O O
of O O
Gram O O
- O O
negative O O
bacteria O O
, O O
whereas O O
nisin O O
had O O
no O O
effect O O
on O O
these O O
in O O
vacuum Habitat_B Habitat_B
packages Habitat_I O
. O O

The O O
Gram O O
- O O
negative O O
flora O O
on O O
vacuum Habitat_B Habitat_B
- Habitat_I Habitat_I
packed Habitat_I Habitat_I
salmon Habitat_I Habitat_I
was O O
dominated O O
by O O
a O O
Vibrio Bacteria_B Bacteria_B
sp Bacteria_I Bacteria_I
. Bacteria_I O
, O O
resembling O O
V Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
marinus Bacteria_I Bacteria_I
, O O
Enterobacteriaceae Bacteria_B O
( O O
Enterobacter Bacteria_B Bacteria_B
agglomerans Bacteria_I Bacteria_I
, O O
Serratia Bacteria_B Bacteria_B
liquefaciens Bacteria_I Bacteria_I
and O O
Rahnella Bacteria_B Bacteria_B
aquatilis Bacteria_I Bacteria_I
) O O
and O O
occasionally O O
Aeromonas Bacteria_B Bacteria_B
hydrophila Bacteria_I Bacteria_I
. O O

Irrespective O O
of O O
the O O
addition O O
of O O
nisin O O
and O O
/ O O
or O O
CO2 O O
- O O
atmosphere O O
, O O
the O O
LAB Habitat_B O
microflora Habitat_I O
was O O
dominated O O
by O O
Carnobacterium Bacteria_B Bacteria_B
piscicola Bacteria_I Bacteria_I
, O O
which O O
was O O
found O O
to O O
account O O
for O O
87 O O
% O O
of O O
the O O
255 O O
LAB Bacteria_B O
isolates O O
characterized O O
. O O

Whole O O
- O O
cell O O
- O O
protein O O
patterns O O
analysed O O
by O O
SDS O O
- O O
PAGE O O
confirmed O O
the O O
Carnobacterium Bacteria_B O
species O O
identification O O
. O O

The O O
spoilage O O
potential O O
of O O
C Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
piscicola Bacteria_I Bacteria_I
isolates O O
was O O
further O O
studied O O
by O O
inoculation O O
of O O
approx O O
. O O

10 O O
( O O
6 O O
) O O
cfu O O
/ O O
g O O
in O O
cold Habitat_B O
- Habitat_I O
smoked Habitat_I O
salmon Habitat_I O
stored Habitat_I O
at Habitat_I O
5 Habitat_I O
degrees Habitat_I O
C Habitat_I O
. O O
The O O
salmon Habitat_B O
did O O
not O O
spoil O O
within O O
4 O O
weeks O O
of O O
storage O O
in O O
vacuum O O
- O O
or O O
CO2 O O
- O O
atmosphere O O
, O O
and O O
it O O
is O O
concluded O O
that O O
despite O O
high O O
levels O O
( O O
> O O
10 O O
( O O
7 O O
) O O
cfu O O
/ O O
g O O
) O O
of O O
C Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
piscicola Bacteria_I Bacteria_I
, O O
sensory O O
rejection O O
was O O
caused O O
by O O
autolytic O O
changes O O
. O O

This O O
was O O
supported O O
by O O
the O O
development O O
of O O
soft O O
texture O O
and O O
sour O O
, O O
rancid O O
and O O
bitter O Habitat_B
off O Habitat_I
- O Habitat_I
flavours O Habitat_I
at O O
the O O
point O O
of O O
spoilage O O
, O O
irrespective O O
of O O
the O O
length O O
of O O
shelf O O
- O O
life O O
and O O
low O O
or O O
high O O
total O O
counts O O
of O O
LAB Bacteria_B O
and O O
Gram O O
- O O
negative O O
bacteria O O
. O O

A O O
cell O O
- O O
free O O
system O O
for O O
the O O
replication O O
fo O O
bacteriophage O O
M O O
- O O
13 O O
duplex O O
DNA O O
. O O

Cell O O
- O O
free O O
extracts O O
from O O
M O O
- O O
13 O O
am5 O O
infected O O
Escherichia Bacteria_B Bacteria_B
coli Bacteria_I Bacteria_I
cells O O
which O O
are O O
highly O O
concentrated O O
on O O
cellophane Habitat_B Habitat_B
membrane Habitat_I Habitat_I
disks Habitat_I Habitat_I
replicate O O
efficiently O O
endogenous O O
M O O
- O O
13 O O
duplex O O
DNA O O
. O O

If O O
the O O
reaction O O
is O O
carried O O
out O O
in O O
the O O
presence O O
of O O
bromodeoxyuridine O Habitat_B
triphosphate O O
, O O
the O O
majority O O
of O O
the O O
label O O
is O O
found O O
in O O
two O O
classes O O
of O O
hybrid O O
DNA O O
molecules O O
in O O
which O O
either O O
the O O
viral O O
or O O
the O O
complementary O O
strand O O
is O O
newly O O
synthesized O O
. O O

A O O
minor O O
portion O O
of O O
the O O
label O O
is O O
incorporated O O
into O O
fully O O
synthetic O O
duplex O O
DNA O O
. O O

DNA O O
synthesis O O
requires O O
ATP O O
and O O
is O O
inhibited O O
by O O
nalidixic O O
acid O O
, O O
novobiocin O O
, O O
and O O
arabinosylnucleoside O O
triphosphates O O
. O O

Rifampicin O O
blocks O O
preferentially O O
the O O
synthesis O O
of O O
molecules O O
with O O
labeled O O
complementary O O
strands O O
. O O

A O O
similar O O
effect O O
is O O
observed O O
upon O O
addition O O
of O O
the O O
helix O O
- O O
destabilising O O
M O O
- O O
13 O O
gene O O
V O O
protein O O
. O O

In O O
contrast O O
, O O
addition O O
of O O
E Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
coli Bacteria_I Bacteria_I
helix O O
- O O
destabilising O O
protein O O
( O O
Eco Bacteria_B O
HD O O
- O O
protein O O
) O O
stimulates O O
the O O
synthesis O O
of O O
both O O
types O O
of O O
hybrid O O
DNA O O
molecules O O
as O O
well O O
as O O
the O O
formation O O
of O O
fully O O
synthetic O O
duplex O O
DNA O O
. O O

Bile Habitat_B O
resistance O O
in O O
Lactococcus Bacteria_B Bacteria_B
lactis Bacteria_I Bacteria_I
strains O O
varies O O
with O O
cellular O O
fatty O O
acid O O
composition O O
: O O
analysis O O
by O O
using O O
different O O
growth O O
media O O
. O O

Bile Habitat_B O
resistance O O
is O O
one O O
of O O
the O O
basic O O
characteristics O O
of O O
probiotic O O
bacteria O O
. O O

The O O
aim O O
of O O
this O O
study O O
was O O
to O O
investigate O O
the O O
characteristics O O
of O O
bile Habitat_B O
resistance O O
in O O
lactococci Bacteria_B O
by O O
studying O O
the O O
relationship O O
between O O
bile Habitat_B Habitat_B
resistance O O
and O O
cellular O O
fatty O O
acid O O
composition O O
in O O
lactococcci Bacteria_B O
grown O O
on O O
different O O
media O O
. O O

We O O
determined O O
the O O
bile Habitat_B O
resistance O O
of O O
14 O O
strains O O
in O O
lactose O Habitat_B
- O Habitat_I
free O Habitat_I
M17 O Habitat_I
medium O Habitat_I
supplemented O O
with O O
either O O
glucose O O
only O O
( O O
GM17 O O
) O O
or O O
lactose O O
only O O
( O O
LM17 O O
) O O
. O O

Gas O O
chromatographic O O
analyses O O
of O O
free O O
lipids O O
extracted O O
from O O
the O O
tested O O
strains O O
were O O
used O O
for O O
determining O O
their O O
fatty O O
acid O O
composition O O
. O O

A O O
correlation O O
analysis O O
of O O
all O O
strains O O
grown O O
in O O
both O O
media O O
revealed O O
significant O O
positive O O
correlations O O
between O O
bile Habitat_B O
resistance O O
and O O
relative O O
contents O O
of O O
hexadecanoic O O
acid O O
and O O
octadecenoic O O
acid O O
, O O
and O O
negative O O
correlations O O
between O O
bile Habitat_B O
resistance O O
and O O
relative O O
contents O O
of O O
hexadecenoic O O
acid O O
and O O
C O O
- O O
19 O O
cyclopropane O O
fatty O O
acid O O
. O O

It O O
is O O
also O O
a O O
fact O O
that O O
the O O
fatty O O
acids O O
associated O O
with O O
bile Habitat_B O
resistance O O
depended O O
on O O
species O O
, O O
strain O O
, O O
and O O
/ O O
or O O
growth O O
medium O O
. O O

In O O
L Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
lactis Bacteria_I Bacteria_I
subsp Bacteria_I Bacteria_I
. Bacteria_I Bacteria_I
Bacteria_I Bacteria_I Bacteria_I
cremoris O Bacteria_I
strains O O
grown O O
in O O
GM17 Habitat_B Habitat_B
medium Habitat_I Habitat_I
, O O
the O O
bile Habitat_B O
- O O
resistant O O
strains O O
had O O
significantly O O
more O O
octadecenoic O O
acid O O
than O O
the O O
bile Habitat_B O
- O O
sensitive O O
strains O O
. O O

In O O
LM17 Habitat_B O
medium Habitat_I O
, O O
bile Habitat_B O
- O O
resistant O O
strains O O
had O O
significantly O O
more O O
octadecenoic O O
acid O O
and O O
significantly O O
less O O
C O O
- O O
19 O O
cyclopropane O O
fatty O O
acid O O
than O O
the O O
bile Habitat_B O
- O O
sensitive O O
strains O O
. O O

In O O
L Bacteria_B Bacteria_B
. Bacteria_I Bacteria_I
lactis Bacteria_I Bacteria_I
subsp Bacteria_I Bacteria_I
. Bacteria_I Bacteria_I
Bacteria_I Bacteria_I Bacteria_I
lactis O Bacteria_I
strains O O
, O O
bile Habitat_B O
resistances O O
of O O
some O O
of O O
the O O
tested O O
strains O O
were O O
altered O O
by O O
growth O O
medium O O
. O O

Some O O
strains O O
were O O
resistant O O
to O O
bile Habitat_B O
in O O
GM17 Habitat_B Habitat_B
medium Habitat_I Habitat_I
but O O
sensitive O O
to O O
bile Habitat_B O
in O O
LM17 Habitat_B Habitat_B
medium Habitat_I Habitat_I
. O O

Some O O
strains O O
were O O
resistant O O
in O O
both O O
media O O
tested O O
. O O

The O O
strains O O
grown O O
in O O
GM17 Habitat_B Habitat_B
medium Habitat_I Habitat_I
had O O
significantly O O
more O O
hexadecanoic O O
acid O O
and O O
octadecenoic O O
acid O O
, O O
and O O
significantly O O
less O O
tetradecanoic O O
acid O O
, O O
octadecadienoic O O
acid O O
and O O
C O O
- O O
19 O O
cyclopropane O O
fatty O O
acid O O
than O O
the O O
strains O O
grown O O
in O O
LM17 Habitat_B Habitat_B
medium Habitat_I Habitat_I
. O O

In O O
conclusion O O
, O O
the O O
fatty O O
acid O O
compositions O O
of O O
the O O
bile Habitat_B O
- O O
resistant O O
lactococci Bacteria_B O
differed O O
from O O
those O O
of O O
the O O
bile Habitat_B O
- O O
sensitive O O
ones O O
. O O

More O O
importantly O O
, O O
our O O
data O O
suggest O O
that O O
altering O O
their O O
fatty O O
acid O O
composition O O
( O O
i O O
. O O
e O O
. O O

increased O O
hexadecanoic O O
acid O O
and O O
octadecenoic O O
acid O O
and O O
decreased O O
hexadecenoic O O
acid O O
and O O
C O O
- O O
19 O O
cyclopropane O O
fatty O O
acid O O
) O O
by O O
changing O O
growth O O
conditions O O
may O O
be O O
a O O
useful O O
way O O
to O O
enhance O O
their O O
bile Habitat_B O
resistance O O
in O O
lactococci Bacteria_B O
. O O


